Keywords
Last Name
Institution

James F. Holland

TitlePROFESSOR
InstitutionMount Sinai
DepartmentHematology and Medical Oncology
Address1470 Madison Avenue
3rd floor
New York NY 10029
Phone212-241-6756
    Other Positions
    TitlePROFESSOR
    InstitutionMount Sinai
    DepartmentOncological Sciences


     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Deligdisch L, Marin T, Lee AT, Etkind P, Holland JF, Melana S, Pogo BG. Human Mammary Tumor Virus (HMTV) in Endometrial Carcinoma. Int J Gynecol Cancer. 2013 Oct; 23(8):1423-8.
      View in: PubMed
    2. Holland JF, Freireich EJ. Emil Frei III, 1924-2013. J Clin Oncol. 2013 Oct 20; 31(30):3727-30.
      View in: PubMed
    3. Ohnuma T, Lehrer D, Ren C, Cho SY, Maniar M, Silverman L, Sung M, Gretz HF, Benisovich V, Navada S, Akahoho E, Wilck E, Taft DR, Roboz J, Wilhelm F, Holland JF. Phase 1 study of intravenous rigosertib (ON 01910.Na), a novel benzyl styryl sulfone structure producing G2/M arrest and apoptosis, in adult patients with advanced cancer. Am J Cancer Res. 2013; 3(3):323-38.
      View in: PubMed
    4. Olukolu BA, Negeri A, Dhawan R, Venkata BP, Sharma P, Garg A, Gachomo E, Marla S, Chu K, Hasan A, Ji J, Chintamanani S, Green J, Shyu CR, Wisser R, Holland J, Johal G, Balint-Kurti P. A connected set of genes associated with programmed cell death implicated in controlling the hypersensitive response in maize. Genetics. 2013 Feb; 193(2):609-20.
      View in: PubMed
    5. Mohammed SI, Williams CK, Ndom P, Holland JF. The African Organization for Research and Training in Cancer: historical perspective. Curr Oncol. 2012 Oct; 19(5):272-6.
      View in: PubMed
    6. Waddell N, Stein SR, Wagner SA, Bennett I, Djougarian A, Melana S, Jaffer S, Holland JF, Pogo BG, Gonda TJ, Brown MA, Leo P, Saunders NA, McMillan NA, Cocciardi S, Vargas AC, Lakhani SR, Chenevix-Trench G, Newman B, Francis GD. Morphological and molecular analysis of a breast cancer cluster at the ABC Studio in Toowong. Pathology. 2012 Aug; 44(5):469-72.
      View in: PubMed
    7. Holland JF, Pogo BG. Comment on the review by Joshi and Buehring. Breast Cancer Res Treat. 2012 Nov; 136(1):303-7.
      View in: PubMed
    8. Lu M, Merali S, Gordon R, Jiang J, Li Y, Mandeli J, Duan X, Fallon J, Holland JF. Prevention of Doxorubicin cardiopathic changes by a benzyl styryl sulfone in mice. Genes Cancer. 2011 Oct; 2(10):985-92.
      View in: PubMed
    9. Oussenko IA, Holland JF, Reddy EP, Ohnuma T. Effect of ON 01910.Na, an anticancer mitotic inhibitor, on cell-cycle progression correlates with RanGAP1 hyperphosphorylation. Cancer Res. 2011 Jul 15; 71(14):4968-76.
      View in: PubMed
    10. Platica M, Ionescu A, Ivan E, Holland JF, Mandeli J, Platica O. PAR, a protein involved in the cell cycle, is functionally related to chromosomal passenger proteins. Int J Oncol. 2011 Mar; 38(3):777-85.
      View in: PubMed
    11. Pogo BG, Melana SM, Moran H, Holland JF. Presence of MMTV-like env gene sequences in human breast cancer. Breast Cancer Res Treat. 2011 Jan; 125(1):295-7.
      View in: PubMed
    12. Pogo BG, Holland JF, Levine PH. Human mammary tumor virus in inflammatory breast cancer. Cancer. 2010 Jun 1; 116(11 Suppl):2741-4.
      View in: PubMed
    13. Cho SY, Ohnuma T, Silverman LR, Holland JF, Roboz J. Discontinuous drug binding to proteins: binding of an antineoplastic benzyl styryl sulfone to albumin and enzymes in vitro and in phase I clinical trials. Drug Metab Dispos. 2010 Sep; 38(9):1480-5.
      View in: PubMed
    14. Melana SM, Nepomnaschy I, Hasa J, Djougarian A, Djougarian A, Holland JF, Pogo BG. Detection of human mammary tumor virus proteins in human breast cancer cells. J Virol Methods. 2010 Jan; 163(1):157-61.
      View in: PubMed
    15. Holland J, Van Exel NJ, Schut FT, Brouwer WB. Some pain, no gain: experiences with the no-claim rebate in the Dutch health care system. Health Econ Policy Law. 2009 Oct; 4(Pt 4):405-24.
      View in: PubMed
    16. Song L, Ohnuma T, Gelman IH, Holland JF. Reovirus infection of cancer cells is not due to activated Ras pathway. Cancer Gene Ther. 2009 Apr; 16(4):382.
      View in: PubMed
    17. Holland JF. Breaking the cure barrier 25 years later. J Clin Oncol. 2008 Apr 1; 26(10):1575.
      View in: PubMed
    18. Melana SM, Nepomnaschy I, Sakalian M, Abbott A, Hasa J, Holland JF, Pogo BG. Characterization of viral particles isolated from primary cultures of human breast cancer cells. Cancer Res. 2007 Sep 15; 67(18):8960-5.
      View in: PubMed
    19. Strauchen JA, Cuttner J, Holland JF. Haemangioblastic transformation of myeloproliferative disease? Br J Haematol. 2007 Sep; 138(6):819-21.
      View in: PubMed
    20. Fernandez-Cobo M, Zammarchi F, Mandeli J, Holland JF, Pogo BG. Expression of Wnt5A and Wnt10B in non-immortalized breast cancer cells. Oncol Rep. 2007 Apr; 17(4):903-7.
      View in: PubMed
    21. Fernandez-Cobo M, Melana SM, Holland JF, Pogo BG. Transcription profile of a human breast cancer cell line expressing MMTV-like sequences. Infect Agent Cancer. 2006; 1:7.
      View in: PubMed
    22. Silverman LR, McKenzie DR, Peterson BL, Holland JF, Backstrom JT, Beach CL, Larson RA. Further analysis of trials with azacitidine in patients with myelodysplastic syndrome: studies 8421, 8921, and 9221 by the Cancer and Leukemia Group B. J Clin Oncol. 2006 Aug 20; 24(24):3895-903.
      View in: PubMed
    23. Schilsky RL, McIntyre OR, Holland JF, Frei E. A concise history of the cancer and leukemia group B. Clin Cancer Res. 2006 Jun 1; 12(11 Pt 2):3553s-5s.
      View in: PubMed
    24. Fernandez-Cobo M, Holland JF, Pogo BG. Transcription profiles of non-immortalized breast cancer cell lines. BMC Cancer. 2006; 6:99.
      View in: PubMed
    25. Cortes EP, Holland JF, Wang JJ, Sinks LF, Blom J, Senn H, Bank A, Glidewell O. The Classic: amputation and adriamycin in primary osteosarcoma. 1974. Clin Orthop Relat Res. 2005 Sep; 438:5-8.
      View in: PubMed
    26. Holland J, Roberts J. Chlamydia trachomatis PCR positivity and inflammatory changes on cervical cytology. Sex Transm Infect. 2005 Aug; 81(4):360-1.
      View in: PubMed
    27. Gumireddy K, Reddy MV, Cosenza SC, Boominathan R, Boomi Nathan R, Baker SJ, Papathi N, Jiang J, Holland J, Reddy EP. ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent. Cancer Cell. 2005 Mar; 7(3):275-86.
      View in: PubMed
    28. Rahaman J, Dottino P, Jennings TS, Holland J, Cohen CJ. The second-look operation improves survival in suboptimally debulked stage III ovarian cancer patients. Int J Gynecol Cancer. 2005 Jan-Feb; 15(1):19-25.
      View in: PubMed
    29. Pogo B, Menard S, Holland JF. Contribution by Faedo et al. (Clin cancer res 2004;10:4417-4419). Clin Cancer Res. 2005 Jan 1; 11(1):406; author reply 406.
      View in: PubMed
    30. Holland JF, Pogo BG. Mouse mammary tumor virus-like viral infection and human breast cancer. Clin Cancer Res. 2004 Sep 1; 10(17):5647-9.
      View in: PubMed
    31. Ramirez FC, Holland JF, Harker J, Leung FW. Effect of acid on duodenal blood flow and mucus secretion measured by reflectance spectrophotometry: a prospective, randomized-controlled study. Aliment Pharmacol Ther. 2004 Sep 1; 20(5):517-25.
      View in: PubMed
    32. Levine PH, Pogo BG, Klouj A, Coronel S, Woodson K, Melana SM, Mourali N, Holland JF. Increasing evidence for a human breast carcinoma virus with geographic differences. Cancer. 2004 Aug 15; 101(4):721-6.
      View in: PubMed
    33. Wang Y, Jiang JD, Xu D, Li Y, Qu C, Holland JF, Pogo BG. A mouse mammary tumor virus-like long terminal repeat superantigen in human breast cancer. Cancer Res. 2004 Jun 15; 64(12):4105-11.
      View in: PubMed
    34. Platica M, Ivan E, Ionescu A, Holland JF, Mora G, Tindall DJ, Mandeli J, Unger PD, Platica O. Transformation of NIH 3T3 cells by enhanced PAR expression. Biochem Biophys Res Commun. 2004 Feb 13; 314(3):891-6.
      View in: PubMed
    35. Platica M, Ivan E, Holland JF, Ionescu A, Chen S, Mandeli J, Unger PD, Platica O. A pituitary gene encodes a protein that produces differentiation of breast and prostate cancer cells. Proc Natl Acad Sci U S A. 2004 Feb 10; 101(6):1560-5.
      View in: PubMed
    36. Kornblith AB, Herndon JE, Weiss RB, Zhang C, Zuckerman EL, Rosenberg S, Mertz M, Payne D, Jane Massie M, Holland JF, Wingate P, Norton L, Holland JC. Long-term adjustment of survivors of early-stage breast carcinoma, 20 years after adjuvant chemotherapy. Cancer. 2003 Aug 15; 98(4):679-89.
      View in: PubMed
    37. Lehrer S, Roboz J, Ding H, Zhao S, Diamond EJ, Holland JF, Stone NN, Droller MJ, Stock RG. Putative protein markers in the sera of men with prostatic neoplasms. BJU Int. 2003 Aug; 92(3):223-5.
      View in: PubMed
    38. Li JN, Song DQ, Lin YH, Hu QY, Yin L, Bekesi G, Holland JF, Jiang JD. Inhibition of microtubule polymerization by 3-bromopropionylamino benzoylurea (JIMB01), a new cancericidal tubulin ligand. Biochem Pharmacol. 2003 May 15; 65(10):1691-9.
      View in: PubMed
    39. Weiss RB, Woolf SH, Demakos E, Holland JF, Berry DA, Falkson G, Cirrincione CT, Robbins A, Bothun S, Henderson IC, Norton L. Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B. J Clin Oncol. 2003 May 1; 21(9):1825-35.
      View in: PubMed
    40. Henderson IC, Berry DA, Demetri GD, Cirrincione CT, Goldstein LJ, Martino S, Ingle JN, Cooper MR, Hayes DF, Tkaczuk KH, Fleming G, Holland JF, Duggan DB, Carpenter JT, Frei E, Schilsky RL, Wood WC, Muss HB, Norton L. Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer. J Clin Oncol. 2003 Mar 15; 21(6):976-83.
      View in: PubMed
    41. Ling YH, Liebes L, Jiang JD, Holland JF, Elliott PJ, Adams J, Muggia FM, Perez-Soler R. Mechanisms of proteasome inhibitor PS-341-induced G(2)-M-phase arrest and apoptosis in human non-small cell lung cancer cell lines. Clin Cancer Res. 2003 Mar; 9(3):1145-54.
      View in: PubMed
    42. Citron ML, Berry DA, Cirrincione C, Hudis C, Winer EP, Gradishar WJ, Davidson NE, Martino S, Livingston R, Ingle JN, Perez EA, Carpenter J, Hurd D, Holland JF, Smith BL, Sartor CI, Leung EH, Abrams J, Schilsky RL, Muss HB, Norton L. Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741. J Clin Oncol. 2003 Apr 15; 21(8):1431-9.
      View in: PubMed
    43. Wang Y, Melana SM, Baker B, Bleiweiss I, Fernandez-Cobo M, Mandeli JF, Holland JF, Pogo BG. High prevalence of MMTV-like env gene sequences in gestational breast cancer. Med Oncol. 2003; 20(3):233-6.
      View in: PubMed
    44. Peterson BA, Petroni GR, Frizzera G, Barcos M, Bloomfield CD, Nissen NI, Hurd DD, Henderson ES, Sartiano GP, Johnson JL, Holland JF, Gottlieb AJ. Prolonged single-agent versus combination chemotherapy in indolent follicular lymphomas: a study of the cancer and leukemia group B. J Clin Oncol. 2003 Jan 1; 21(1):5-15.
      View in: PubMed
    45. Jiang JD, Denner L, Ling YH, Li JN, Davis A, Wang Y, Li Y, Roboz J, Wang LG, Perez-Soler R, Marcelli M, Bekesi G, Holland JF. Double blockade of cell cycle at g(1)-s transition and m phase by 3-iodoacetamido benzoyl ethyl ester, a new type of tubulin ligand. Cancer Res. 2002 Nov 1; 62(21):6080-8.
      View in: PubMed
    46. Liu XH, Kirschenbaum A, Lu M, Yao S, Dosoretz A, Holland JF, Levine AC. Prostaglandin E2 induces hypoxia-inducible factor-1alpha stabilization and nuclear localization in a human prostate cancer cell line. J Biol Chem. 2002 Dec 20; 277(51):50081-6.
      View in: PubMed
    47. Ling YH, Jiang JD, Holland JF, Perez-Soler R. Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines. Mol Pharmacol. 2002 Sep; 62(3):529-38.
      View in: PubMed
    48. Kornblith AB, Herndon JE, Silverman LR, Demakos EP, Odchimar-Reissig R, Holland JF, Powell BL, DeCastro C, Ellerton J, Larson RA, Schiffer CA, Holland JC. Impact of azacytidine on the quality of life of patients with myelodysplastic syndrome treated in a randomized phase III trial: a Cancer and Leukemia Group B study. J Clin Oncol. 2002 May 15; 20(10):2441-52.
      View in: PubMed
    49. Silverman LR, Demakos EP, Peterson BL, Kornblith AB, Holland JC, Odchimar-Reissig R, Stone RM, Nelson D, Powell BL, DeCastro CM, Ellerton J, Larson RA, Schiffer CA, Holland JF. Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B. J Clin Oncol. 2002 May 15; 20(10):2429-40.
      View in: PubMed
    50. Naughton MJ, Herndon JE, Shumaker SA, Miller AA, Kornblith AB, Chao D, Holland J. The health-related quality of life and survival of small-cell lung cancer patients: results of a companion study to CALGB 9033. Qual Life Res. 2002 May; 11(3):235-48.
      View in: PubMed
    51. Liu XH, Kirschenbaum A, Lu M, Yao S, Klausner A, Preston C, Holland JF, Levine AC. Prostaglandin E(2) stimulates prostatic intraepithelial neoplasia cell growth through activation of the interleukin-6/GP130/STAT-3 signaling pathway. Biochem Biophys Res Commun. 2002 Jan 11; 290(1):249-55.
      View in: PubMed
    52. Melana SM, Picconi MA, Rossi C, Mural J, Alonio LV, Teyssié A, Holland JF, Pogo BG. [Detection of murine mammary tumor virus (MMTV) env gene-like sequences in breast cancer from Argentine patients]. Medicina (B Aires). 2002; 62(4):323-7.
      View in: PubMed
    53. Platica M, Ivan E, Chen S, Holland JF, Gil J, Mandeli J, Platica O. Stable lower PAR expression decreased DU145 prostate cancer cell growth in SCID mice. Prostate. 2001 Nov 1; 49(3):200-7.
      View in: PubMed
    54. Ang E, Chen J, Zagouras P, Magna H, Holland J, Schaeffer E, Nestler EJ. Induction of nuclear factor-kappaB in nucleus accumbens by chronic cocaine administration. J Neurochem. 2001 Oct; 79(1):221-4.
      View in: PubMed
    55. Holland AJ, Holland J, Martin HC, Cummins G, Cooke-Yarborough C, Cass DT. Noncervicofacial atypical mycobacterial lymphadenitis in childhood. J Pediatr Surg. 2001 Sep; 36(9):1337-40.
      View in: PubMed
    56. Lockyer AE, Jones CS, Noble LR, Verspoor E, Holland J, Secombes CJ. Isolation and characterisation of a putative interleukin 13 receptor a2 sequence from rainbow trout (Oncorhynchus mykiss). Fish Shellfish Immunol. 2001 Aug; 11(6):541-6.
      View in: PubMed
    57. Laing KJ, Holland J, Bonilla S, Cunningham C, Secombes CJ. Cloning and sequencing of caspase 6 in rainbow trout, Oncorhynchus mykiss, and analysis of its expression under conditions known to induce apoptosis. Dev Comp Immunol. 2001 May; 25(4):303-12.
      View in: PubMed
    58. Slater MS, Holland J, Faigel DO, Sheppard BC, Deveney CW. Does neoadjuvant chemoradiation downstage esophageal carcinoma? Am J Surg. 2001 May; 181(5):440-4.
      View in: PubMed
    59. Jiang JD, Zhang H, Li JN, Roboz J, Qiao WB, Holland JF, Bekesi G. High anticancer efficacy of L-proline-m-bis (2-chloroethyl) amino-L-phenylalanyl-L-norvaline ethyl ester hydrochloride (MF13) in vivo. Anticancer Res. 2001 May-Jun; 21(3B):1681-9.
      View in: PubMed
    60. Wang Y, Pelisson I, Melana SM, Holland JF, Pogo BG. Detection of MMTV-like LTR and LTR-env gene sequences in human breast cancer. Int J Oncol. 2001 May; 18(5):1041-4.
      View in: PubMed
    61. Paterson AG, Trask PC, Schwartz SM, Deaner SL, Riba M, Holland J, Fleishman SB, Breitbart W. Screening and treatment of distress. J Consult Clin Psychol. 2001 Apr; 69(2):339.
      View in: PubMed
    62. Laing KJ, Wang T, Zou J, Holland J, Hong S, Bols N, Hirono I, Aoki T, Secombes CJ. Cloning and expression analysis of rainbow trout Oncorhynchus mykiss tumour necrosis factor-alpha. Eur J Biochem. 2001 Mar; 268(5):1315-22.
      View in: PubMed
    63. Liu B, Wang Y, Melana SM, Pelisson I, Najfeld V, Holland JF, Pogo BG. Identification of a proviral structure in human breast cancer. Cancer Res. 2001 Feb 15; 61(4):1754-9.
      View in: PubMed
    64. Melana SM, Holland JF, Pogo BG. Search for mouse mammary tumor virus-like env sequences in cancer and normal breast from the same individuals. Clin Cancer Res. 2001 Feb; 7(2):283-4.
      View in: PubMed
    65. Kornblith AB, Herndon JE, Zuckerman E, Viscoli CM, Horwitz RI, Cooper MR, Harris L, Tkaczuk KH, Perry MC, Budman D, Norton LC, Holland J. Social support as a buffer to the psychological impact of stressful life events in women with breast cancer. Cancer. 2001 Jan 15; 91(2):443-54.
      View in: PubMed
    66. Wang Y, Pelisson I, Melana SM, Go V, Holland JF, Pogo BG. MMTV-like env gene sequences in human breast cancer. Arch Virol. 2001; 146(1):171-80.
      View in: PubMed
    67. Halatsch ME, Schmidt U, Bötefür IC, Holland JF, Ohnuma T. Overexpression of deletion-mutant epidermal growth factor receptor is associated with altered genotoxic stress-provoked p53 mRNA induction in a human glioblastoma cell line. Anticancer Res. 2001 Jan-Feb; 21(1A):189-95.
      View in: PubMed
    68. Schlesinger M, Jiang JD, Roboz JP, Denner L, Ling YH, Holland JF, Bekesi JG. 3-m-bromoacetylamino benzoic acid ethyl ester: a new cancericidal agent that activates the apoptotic pathway through caspase-9. Biochem Pharmacol. 2000 Dec 1; 60(11):1693-702.
      View in: PubMed
    69. Liu XH, Kirschenbaum A, Yao S, Lee R, Holland JF, Levine AC. Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo. J Urol. 2000 Sep; 164(3 Pt 1):820-5.
      View in: PubMed
    70. Czabotar PE, Holland J, Sanderson CJ. Identification of regions within the third FnIII-like domain of the IL-5Ralpha involved in IL-5 interaction. Cytokine. 2000 Jul; 12(7):867-73.
      View in: PubMed
    71. Paciucci PA, Ryder JS, Mandell JP, Morris JC, Holland JF. Interleukin-2 plus chemotherapy for patients with metastatic melanoma. Melanoma Res. 2000 Jun; 10(3):291-5.
      View in: PubMed
    72. Platica O, Chen S, Ivan E, Lopingco MC, Holland JF, Platica M. PAR, a novel androgen regulated gene, ubiquitously expressed in normal and malignant cells. Int J Oncol. 2000 May; 16(5):1055-61.
      View in: PubMed
    73. Halatsch ME, Schmidt U, Bötefür IC, Holland JF, Ohnuma T. Marked inhibition of glioblastoma target cell tumorigenicity in vitro by retrovirus-mediated transfer of a hairpin ribozyme against deletion-mutant epidermal growth factor receptor messenger RNA. J Neurosurg. 2000 Feb; 92(2):297-305.
      View in: PubMed
    74. Czabotar PE, Holland J, Sanderson CJ. Identification of residues involved in binding of IL5 to betacom using betaIL3 and betacom chimeras. FEBS Lett. 1999 Oct 22; 460(1):99-102.
      View in: PubMed
    75. Saeki T, Takashima S, Tachibana M, Koga M, Hiyama E, Salomon DS, Holland JF, Ohnuma T. Inhibitory effect of telomere-mimic phosphorothioate oligodeoxy nucleotides (S-ODNS) on human tumor cell lines. Oncology. 1999 Oct; 57 Suppl 2:27-36.
      View in: PubMed
    76. Holland JF, Pogo GT. Possible etiology of human breast cancer: comment. Biomed Pharmacother. 1999 Aug; 53(7):334.
      View in: PubMed
    77. Pogo BG, Melana SM, Holland JF, Mandeli JF, Pilotti S, Casalini P, Ménard S. Sequences homologous to the mouse mammary tumor virus env gene in human breast carcinoma correlate with overexpression of laminin receptor. Clin Cancer Res. 1999 Aug; 5(8):2108-11.
      View in: PubMed
    78. Wang FS, Kobayashi H, Liang KW, Holland JF, Ohnuma T. Retrovirus-mediated transfer of anti-MDR1 ribozymes fully restores chemosensitivity of P-glycoprotein-expressing human lymphoma cells. Hum Gene Ther. 1999 May 1; 10(7):1185-95.
      View in: PubMed
    79. Hochster H, Speyer JL, Mandeli JP, Runowicz C, Wadler S, Berk G, Wallach R, Holland JF. A phase II double-blind randomized study of the simultaneous administration of recombinant human interleukin-6 and recombinant human granulocyte colony-stimulating factor following paclitaxel and carboplatin chemotherapy in patients with advanced epithelial ovarian cancer. Gynecol Oncol. 1999 Mar; 72(3):292-7.
      View in: PubMed
    80. Herndon JE, Fleishman S, Kornblith AB, Kosty M, Green MR, Holland J. Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma? Cancer. 1999 Jan 15; 85(2):333-40.
      View in: PubMed
    81. Holland JF. New medicine for the new millennium. Mt Sinai J Med. 1999 Jan; 66(1):35-6.
      View in: PubMed
    82. Baider L, Russak SM, Perry S, Kash K, Gronert M, Fox B, Holland J, Kaplan-Denour A. The role of religious and spiritual beliefs in coping with malignant melanoma: an Israeli sample. Psychooncology. 1999 Jan-Feb; 8(1):27-35.
      View in: PubMed
    83. Liu XH, Kirschenbaum A, Yao S, Stearns ME, Holland JF, Claffey K, Levine AC. Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line. Clin Exp Metastasis. 1999; 17(8):687-94.
      View in: PubMed
    84. Jiang JD, Davis AS, Middleton K, Ling YH, Perez-Soler R, Holland JF, Bekesi JG. 3-(Iodoacetamido)-benzoylurea: a novel cancericidal tubulin ligand that inhibits microtubule polymerization, phosphorylates bcl-2, and induces apoptosis in tumor cells. Cancer Res. 1998 Dec 1; 58(23):5389-95.
      View in: PubMed
    85. Louie M, Read S, Simor AE, Holland J, Louie L, Ziebell K, Brunton J, Hii J. Application of multiplex PCR for detection of non-O157 verocytotoxin-producing Escherichia coli in bloody stools: identification of serogroups O26 and O111. J Clin Microbiol. 1998 Nov; 36(11):3375-7.
      View in: PubMed
    86. Levine AC, Liu XH, Greenberg PD, Eliashvili M, Schiff JD, Aaronson SA, Holland JF, Kirschenbaum A. Androgens induce the expression of vascular endothelial growth factor in human fetal prostatic fibroblasts. Endocrinology. 1998 Nov; 139(11):4672-8.
      View in: PubMed
    87. Badawy SZ, Cuenca V, Kumar S, Holland J. Effects of chocolate cyst fluid on endometrioma cell growth in culture. Fertil Steril. 1998 Nov; 70(5):827-30.
      View in: PubMed
    88. Jiang JD, Roboz J, Weisz I, Deng L, Ma L, Holland JF, Bekesi JG. Synthesis, cancericidal and antimicrotubule activities of 3-(haloacetamido)-benzoylureas. Anticancer Drug Des. 1998 Oct; 13(7):735-47.
      View in: PubMed
    89. Wang Y, Go V, Holland JF, Melana SM, Pogo BG. Expression of mouse mammary tumor virus-like env gene sequences in human breast cancer. Clin Cancer Res. 1998 Oct; 4(10):2565-8.
      View in: PubMed
    90. Zinzar S, Silverman LR, Richardson EB, Bekesi G, Holland JF. Azacytidine plus verapamil induces the differentiation of a newly characterized biphenotypic human myeloid-B lymphoid leukemic cell line BW-90. Leuk Res. 1998 Aug; 22(8):677-85.
      View in: PubMed
    91. O'Mahony L, Holland J, Jackson J, Feighery C, Hennessy TP, Mealy K. Quantitative intracellular cytokine measurement: age-related changes in proinflammatory cytokine production. Clin Exp Immunol. 1998 Aug; 113(2):213-9.
      View in: PubMed
    92. Fields A, Hochster H, Runowicz C, Speyer J, Goldberg G, Cohen C, Dottino P, Wadler S, Berk G, Gretz H, Mandeli J, Holland J, Letvak L. PSC833: initial clinical results in refractory ovarian cancer patients. Curr Opin Oncol. 1998 Aug; 10 Suppl 1:S21.
      View in: PubMed
    93. Coleman M, Rafla S, Propert KJ, Glicksman A, Peterson B, Nissen N, Brunner K, Holland JF, Anderson JR, Gottlieb A, Kaufman T. Augmented therapy of extensive Hodgkin's disease: radiation to known disease or prolongation of induction chemotherapy did not improve survival--results of a Cancer and Leukemia Group B study. Int J Radiat Oncol Biol Phys. 1998 Jun 1; 41(3):639-45.
      View in: PubMed
    94. Jiang JD, Wang Y, Roboz J, Strauchen J, Holland JF, Bekesi JG. Inhibition of microtubule assembly in tumor cells by 3-bromoacetylamino benzoylurea, a new cancericidal compound. Cancer Res. 1998 May 15; 58(10):2126-33.
      View in: PubMed
    95. Holland J, Bastian I, Ratcliff RM, Beers MY, Hahesy P, Harley H, Shaw DR, Higgins GD. Hepatitis C genotyping by direct sequencing of the product from the Roche AMPLICOR test: methodology and application to a South Australian population. Pathology. 1998 May; 30(2):192-5.
      View in: PubMed
    96. Kobayashi H, Takemura Y, Holland JF, Ohnuma T. Vincristine saturation of cellular binding sites and its cytotoxic activity in human lymphoblastic leukemia cells: mechanism of inoculum effect. Biochem Pharmacol. 1998 Apr 15; 55(8):1229-34.
      View in: PubMed
    97. Yokoyama Y, Ito T, Hanson V, Schwartz GK, Aderem AA, Holland JF, Tamaya T, Ohnuma T. PMA-induced reduction in invasiveness is associated with hyperphosphorylation of MARCKS and talin in invasive bladder cancer cells. Int J Cancer. 1998 Mar 2; 75(5):774-9.
      View in: PubMed
    98. Melana SM, Holland JF, Pogo BG. Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by 3'-azido-3'-deoxythymidine. Clin Cancer Res. 1998 Mar; 4(3):693-6.
      View in: PubMed
    99. Chahinian AP, Mandeli JP, Gluck H, Naim H, Teirstein AS, Holland JF. Effectiveness of cisplatin, paclitaxel, and suramin against human malignant mesothelioma xenografts in athymic nude mice. J Surg Oncol. 1998 Feb; 67(2):104-11.
      View in: PubMed
    100. Jiang JD, Wang Y, Janish CA, Holland JF, Bekesi JG. 3-Bromoacetylamino benzoylurea (3-BAABU), a new antimicrotubule cancericidal agent applied in cytogenetic analysis in hematology. Biomed Pharmacother. 1998; 52(6):270-81.
      View in: PubMed
    101. Roboz J, Deng L, Ma L, Holland JF. Investigation of suramin-albumin binding by electrospray mass spectrometry. Rapid Commun Mass Spectrom. 1998; 12(19):1319-22.
      View in: PubMed
    102. Masuda Y, Kobayashi H, Holland JF, Ohnuma T. Reversal of multidrug resistance by a liposome-MDR1 ribozyme complex. Cancer Chemother Pharmacol. 1998; 42(1):9-16.
      View in: PubMed
    103. Hill JM, Kornblith AB, Jones D, Freeman A, Holland JF, Glicksman AS, Boyett JM, Lenherr B, Brecher ML, Dubowy R, Kung F, Maurer H, Holland JC. A comparative study of the long term psychosocial functioning of childhood acute lymphoblastic leukemia survivors treated by intrathecal methotrexate with or without cranial radiation. Cancer. 1998 Jan 1; 82(1):208-18.
      View in: PubMed
    104. Paciucci PA, Cuttner J, Gottlieb A, Davis RB, Martelo O, Holland JF. Sequential mitoxantrone, daunorubicin, and cytosine arabinoside for patients with newly diagnosed acute myelocytic leukemia. Am J Hematol. 1997 Dec; 56(4):214-8.
      View in: PubMed
    105. Holland JF. Clinical trials in cancer. Clin Cancer Res. 1997 Dec; 3(12 Pt 2):2585-6.
      View in: PubMed
    106. Roboz J, Jiang J, Holland JF, Bekesi JG. Selective tumor apoptosis by MF13, L-prolyl-L-m-[bis(chloroethyl)amino]-phenylalanyl-L-norvaline ethyl ester, a new sarcolysin containing tripeptide. Cancer Res. 1997 Nov 1; 57(21):4795-802.
      View in: PubMed
    107. Ohnuma T, Li FL, Holland JF. Inhibitory effects of telomere-mimic phosphorothioate oligonucleotides on various human tumor cells in vitro. Anticancer Res. 1997 Jul-Aug; 17(4A):2455-8.
      View in: PubMed
    108. Portenoy RK, Coyle N, Kash KM, Brescia F, Scanlon C, O'Hare D, Misbin RI, Holland J, Foley KM. Determinants of the willingness to endorse assisted suicide. A survey of physicians, nurses, and social workers. Psychosomatics. 1997 May-Jun; 38(3):277-87.
      View in: PubMed
    109. Sinkowitz RL, Keyserling H, Walker TJ, Holland J, Jarvis WR. Epidemiology of vancomycin usage at a children's hospital, 1993 through 1995. Pediatr Infect Dis J. 1997 May; 16(5):485-9.
      View in: PubMed
    110. Holland J, Owens T. Signaling through intercellular adhesion molecule 1 (ICAM-1) in a B cell lymphoma line. The activation of Lyn tyrosine kinase and the mitogen-activated protein kinase pathway. J Biol Chem. 1997 Apr 4; 272(14):9108-12.
      View in: PubMed
    111. Freeman AI, Boyett JM, Glicksman AS, Brecher ML, Leventhal BG, Sinks LF, Holland JF. Intermediate-dose methotrexate versus cranial irradiation in childhood acute lymphoblastic leukemia: a ten-year follow-up. Med Pediatr Oncol. 1997 Feb; 28(2):98-107.
      View in: PubMed
    112. Holland J, Smith C, Childs PA, Holland AJ. Surgical management of cutaneous infection caused by atypical mycobacteria after penetrating injury: the hidden dangers of horticulture. J Trauma. 1997 Feb; 42(2):337-40.
      View in: PubMed
    113. Pogo BG, Holland JF. Possibilities of a viral etiology for human breast cancer. A review. Biol Trace Elem Res. 1997 Jan; 56(1):131-42.
      View in: PubMed
    114. Pogo BG, Holland JF, Wang Y, Melana SM, Pelisson I, Liu B, Go V, Bleiweiss I. [Searching for retroviral sequences related to human breast cancer]. Medicina (B Aires). 1997; 57 Suppl 2:75-80.
      View in: PubMed
    115. Kirschenbaum A, Wang JP, Ren M, Schiff JD, Aaronson SA, Droller MJ, Ferrara N, Holland JF, Levine AC. Inhibition of vascular endothelial cell growth factor suppresses the in vivo growth of human prostate tumors. Urol Oncol. 1997 Jan-Feb; 3(1):3-10.
      View in: PubMed
    116. Zakowski SG, Valdimarsdottir HB, Bovbjerg DH, Borgen P, Holland J, Kash K, Miller D, Mitnick J, Osborne M, Van Zee K. Predictors of intrusive thoughts and avoidance in women with family histories of breast cancer. Ann Behav Med. 1997; 19(4):362-9.
      View in: PubMed
    117. Baider L, Perry S, Sison A, Holland J, Uziely B, DeNour AK. The role of psychological variables in a group of melanoma patients. An Israeli sample. Psychosomatics. 1997 Jan-Feb; 38(1):45-53.
      View in: PubMed
    118. Holland J, Parsons TR, Hasan AA, Cook SM, Stevenson P, Griffiths E, Williams P. Conservation and antigenic cross-reactivity of the transferrin-binding proteins of Haemophilus influenzae, Actinobacillus pleuropneumoniae and Neisseria meningitidis. Microbiology. 1996 Dec; 142 ( Pt 12):3505-13.
      View in: PubMed
    119. Holland J, Hersh L, Bryhan M, Onyiriuka E, Ziegler L. Culture of human vascular endothelial cells on an RGD-containing synthetic peptide attached to a starch-coated polystyrene surface: comparison with fibronectin-coated tissue grade polystyrene. Biomaterials. 1996 Nov; 17(22):2147-56.
      View in: PubMed
    120. Roach M, Faillace-Akazawa P, Malfatti C, Holland J, Hricak H. Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys. 1996 Jul 15; 35(5):1011-8.
      View in: PubMed
    121. Roach M, Chinn DM, Holland J, Clarke M. A pilot survey of sexual function and quality of life following 3D conformal radiotherapy for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 1996 Jul 15; 35(5):869-74.
      View in: PubMed
    122. Badawy SZ, Holland J, Landas S, Frankel L, Cuenca V, Khan S. The role of estradiol, progesterone, and transforming growth factor on human endometrioma cell culture. Am J Reprod Immunol. 1996 Jul; 36(1):58-63.
      View in: PubMed
    123. Tross S, Herndon J, Korzun A, Kornblith AB, Cella DF, Holland JF, Raich P, Johnson A, Kiang DT, Perloff M, Norton L, Wood W, Holland JC. Psychological symptoms and disease-free and overall survival in women with stage II breast cancer. Cancer and Leukemia Group B. J Natl Cancer Inst. 1996 May 15; 88(10):661-7.
      View in: PubMed
    124. Perloff M, Norton L, Korzun AH, Wood WC, Carey RW, Gottlieb A, Aust JC, Bank A, Silver RT, Saleh F, Canellos GP, Perry MC, Weiss RB, Holland JF. Postsurgical adjuvant chemotherapy of stage II breast carcinoma with or without crossover to a non-cross-resistant regimen: a Cancer and Leukemia Group B study. J Clin Oncol. 1996 May; 14(5):1589-98.
      View in: PubMed
    125. Runowicz CD, Mandeli J, Speyer JL, Wadler S, Hochster H, Garrison L, Holland JF. Phase I/II study of PIXY321 in combination with cyclophosphamide and carboplatin in the treatment of ovarian cancer. Am J Obstet Gynecol. 1996 Apr; 174(4):1151-9; discussion 1159-60.
      View in: PubMed
    126. Schlesinger M, Silverman LR, Jiang JD, Yagi MJ, Holland JF, Bekesi JG. Analysis of myeloid and lymphoid markers on the surface and in the cytoplasm of mononuclear bone marrow cells in patients with myelodysplastic syndrome. J Clin Lab Immunol. 1996; 48(4):149-66.
      View in: PubMed
    127. Wang Y, Holland JF, Bleiweiss IJ, Melana S, Liu X, Pelisson I, Cantarella A, Stellrecht K, Mani S, Pogo BG. Detection of mammary tumor virus env gene-like sequences in human breast cancer. Cancer Res. 1995 Nov 15; 55(22):5173-9.
      View in: PubMed
    128. Sundaresan N, Sachdev VP, Holland JF, Moore F, Sung M, Paciucci PA, Wu LT, Kelligher K, Hough L. Surgical treatment of spinal cord compression from epidural metastasis. J Clin Oncol. 1995 Sep; 13(9):2330-5.
      View in: PubMed
    129. Chinn DM, Holland J, Crownover RL, Roach M. Potency following high-dose three-dimensional conformal radiotherapy and the impact of prior major urologic surgical procedures in patients treated for prostate cancer. Int J Radiat Oncol Biol Phys. 1995 Aug 30; 33(1):15-22.
      View in: PubMed
    130. Aisner J, Cirrincione C, Perloff M, Perry M, Budman D, Abrams J, Panasci L, Muss H, Citron M, Holland J, et al. Combination chemotherapy for metastatic or recurrent carcinoma of the breast--a randomized phase III trial comparing CAF versus VATH versus VATH alternating with CMFVP: Cancer and Leukemia Group B Study 8281. J Clin Oncol. 1995 Jun; 13(6):1443-52.
      View in: PubMed
    131. Oakley A, Fullerton D, Holland J. Behavioural interventions for HIV/AIDS prevention. AIDS. 1995 May; 9(5):479-86.
      View in: PubMed
    132. Eddleston JM, Pearson RC, Holland J, Tooth JA, Vohra A, Doran BH. Prospective endoscopic study of stress erosions and ulcers in critically ill adult patients treated with either sucralfate or placebo. Crit Care Med. 1994 Dec; 22(12):1949-54.
      View in: PubMed
    133. Dorai T, Kobayashi H, Holland JF, Ohnuma T. Modulation of platelet-derived growth factor-beta mRNA expression and cell growth in a human mesothelioma cell line by a hammerhead ribozyme. Mol Pharmacol. 1994 Sep; 46(3):437-44.
      View in: PubMed
    134. Vorechovský I, Vetrie D, Holland J, Bentley DR, Thomas K, Zhou JN, Notarangelo LD, Plebani A, Fontán G, Ochs HD, et al. Isolation of cosmid and cDNA clones in the region surrounding the BTK gene at Xq21.3-q22. Genomics. 1994 Jun; 21(3):517-24.
      View in: PubMed
    135. Kobayashi H, Dorai T, Holland JF, Ohnuma T. Reversal of drug sensitivity in multidrug-resistant tumor cells by an MDR1 (PGY1) ribozyme. Cancer Res. 1994 Mar 1; 54(5):1271-5.
      View in: PubMed
    136. Holland JF, Bhardwaj S, Norton L. Re: "We may be lost, but we're sure makin' good time". Cancer Invest. 1994; 12(2):270-2.
      View in: PubMed
    137. Wadler S, Haynes H, Beitler JJ, Goldberg G, Holland JF, Hochster H, Bruckner H, Mandeli J, Smith H, Runowicz C. Management of hypocalcemic effects of WR2721 administered on a daily times five schedule with cisplatin and radiation therapy. The New York Gynecologic Oncology Group. J Clin Oncol. 1993 Aug; 11(8):1517-22.
      View in: PubMed
    138. Li XK, Kobayashi H, Holland JF, Ohnuma T. Expression of dihydrofolate reductase and multidrug resistance genes in trimetrexate-resistant human leukemia cell lines. Leuk Res. 1993 Jun; 17(6):483-90.
      View in: PubMed
    139. Passik S, Newman M, Brennan M, Holland J. Psychiatric consultation for women undergoing rehabilitation for upper-extremity lymphedema following breast cancer treatment. J Pain Symptom Manage. 1993 May; 8(4):226-33.
      View in: PubMed
    140. Silverman LR, Holland JF, Weinberg RS, Alter BP, Davis RB, Ellison RR, Demakos EP, Cornell CJ, Carey RW, Schiffer C, et al. Effects of treatment with 5-azacytidine on the in vivo and in vitro hematopoiesis in patients with myelodysplastic syndromes. Leukemia. 1993 May; 7 Suppl 1:21-9.
      View in: PubMed
    141. Griffiths E, Stevenson P, Byfield P, Ala'Aldeen DA, Borriello SP, Holland J, Parsons T, Williams P. Antigenic relationships of transferrin-binding proteins from Neisseria meningitidis, N. gonorrhoeae and Haemophilus influenzae: cross-reactivity of antibodies to NH2-terminal peptides. FEMS Microbiol Lett. 1993 May 1; 109(1):85-91.
      View in: PubMed
    142. Kobayashi H, Dorai T, Holland JF, Ohnuma T. Cleavage of human MDR1 mRNA by a hammerhead ribozyme. FEBS Lett. 1993 Mar 15; 319(1-2):71-4.
      View in: PubMed
    143. Vetrie D, Vorechovský I, Sideras P, Holland J, Davies A, Flinter F, Hammarström L, Kinnon C, Levinsky R, Bobrow M, et al. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature. 1993 Jan 21; 361(6409):226-33.
      View in: PubMed
    144. Roach M, Pickett B, Holland J, Zapotowski KA, Marsh DL, Tatera BS. The role of the urethrogram during simulation for localized prostate cancer. Int J Radiat Oncol Biol Phys. 1993 Jan 15; 25(2):299-307.
      View in: PubMed
    145. Fujii M, Ohnuma T, Szrajer L, Holland JF, Biller H, Okabe M. Effects of mitomycin-C and etoposide in cell culture and in nude mice: the role of G-CSF mutein. Cancer Invest. 1993; 11(3):283-90.
      View in: PubMed
    146. Ohnuma T, Szrajer L, Holland JF, Kurimoto M, Minowada J. Effects of natural interferon alpha, natural tumor necrosis factor alpha and their combination on human mesothelioma xenografts in nude mice. Cancer Immunol Immunother. 1993; 36(1):31-6.
      View in: PubMed
    147. Gennuso R, Spigelman MK, Chinol M, Zappulla RA, Nieves J, Vallabhajosula S, Alberto Paciucci P, Goldsmith SJ, Holland JF. Effect of blood-brain barrier and blood-tumor barrier modification on central nervous system liposomal uptake. Cancer Invest. 1993; 11(2):118-28.
      View in: PubMed
    148. Vorechovský I, Holland J, Sideras P, Dunham I, Hammarström L, Smith CI, Bentley DR, Vetrie D. Isolation of cDNA clones mapping around DXS178: a search for human X-linked agammaglobulinaemia gene using yeast artificial chromosomes, cosmids and direct cDNA selection. Immunodeficiency. 1993; 4(1-4):221-4.
      View in: PubMed
    149. Bhardwaj S, Holland JF, Norton L. An intensive sequenced adjuvant chemotherapy regimen for breast cancer. Cancer Invest. 1993; 11(1):6-9.
      View in: PubMed
    150. Trill MD, Holland J. Cross-cultural differences in the care of patients with cancer. A review. Gen Hosp Psychiatry. 1993 Jan; 15(1):21-30.
      View in: PubMed
    151. Rovet J, Holland J. Psychological aspects of the Canadian randomized controlled trial of human growth hormone and low-dose ethinyl oestradiol in children with Turner syndrome. The Canadian Growth Hormone Advisory Group. Horm Res. 1993; 39 Suppl 2:60-4.
      View in: PubMed
    152. Banerjee R, Bekesi JG, Tarcsafalvi A, Sperber K, Deak G, Choi HS, Paronetto F, Holland JF, Acs G. Productive nonlytic human immunodeficiency virus type 1 replication in a newly established human leukemia cell line. Proc Natl Acad Sci U S A. 1992 Nov 1; 89(21):9996-10000.
      View in: PubMed
    153. Pollin IS, Holland J. A model for counseling the medically ill: the Linda Pollin Foundation approach. Introduction. Gen Hosp Psychiatry. 1992 Nov; 14(6 Suppl):1S-2S.
      View in: PubMed
    154. Kiire CF, Gombe-Mbalawa C, Tsega E, Luande J, Menenses LV, Okoth J, Olweny CL, Holland J. Multicentre study of the treatment of primary liver cancer in Africa with two anthracycline drugs. Cent Afr J Med. 1992 Nov; 38(11):428-31.
      View in: PubMed
    155. Holland JF. Successful successive studies in leukemia and breast cancer. Mt Sinai J Med. 1992 Oct; 59(5):414-5.
      View in: PubMed
    156. Silver RT, Karanas A, Dear KB, Weil M, Brunner K, Haurani F, Holland JF. Attempted prevention of blast crisis in chronic myeloid leukemia by the use of pulsed doses of cytarabine and lomustine. A Cancer and Leukemia Group B study. Leuk Lymphoma. 1992 May; 7(1-2):63-8.
      View in: PubMed
    157. Holland J, Trenkner DA, Wasserman TH, Fineberg B. Plasmacytoma. Treatment results and conversion to myeloma. Cancer. 1992 Mar 15; 69(6):1513-7.
      View in: PubMed
    158. Jiang JD, Chu FN, Naylor PH, Kirkley JE, Mandeli J, Wallace JI, Sarin PS, Goldstein AL, Holland JF, Bekesi JG. Specific antibody responses to synthetic peptides of HIV-1 p17 correlate with different stages of HIV-1 infection. J Acquir Immune Defic Syndr. 1992; 5(4):382-90.
      View in: PubMed
    159. Kikuchi T, Ohnuma T, Holland JF, Spitler LE. Penetration of anti-melanoma immunotoxin into multicellular tumor spheroids and cell kill effects. Cancer Immunol Immunother. 1992; 35(5):302-6.
      View in: PubMed
    160. Schwartz GK, Collins JJ, Galazka A, Nessi PA, Lehrer D, Baldwin Y, Mandeli J, Holland JF. Phase I study of subcutaneously-administered bacterially-synthesised recombinant human granulocyte-macrophage colony-stimulating factor. Eur J Cancer. 1992; 28(2-3):470-3.
      View in: PubMed
    161. Oleksowicz L, Paciucci PA, Zuckerman D, Colorito A, Rand JH, Holland JF. Alterations of platelet function induced by interleukin-2. J Immunother (1991). 1991 Oct; 10(5):363-70.
      View in: PubMed
    162. Nakahori Y, Knight SJ, Holland J, Schwartz C, Roche A, Tarleton J, Wong S, Flint TJ, Froster-Iskenius U, Bentley D, et al. Molecular heterogeneity of the fragile X syndrome. Nucleic Acids Res. 1991 Aug 25; 19(16):4355-9.
      View in: PubMed
    163. Paciucci PA, Bekesi JG, Ryder JS, Odchimar R, Chahinian PA, Holland JF. Immunotherapy with IL2 by constant infusion and weekly doxorubicin. Am J Clin Oncol. 1991 Aug; 14(4):341-8.
      View in: PubMed
    164. Chahinian AP, Kirschner PA, Gordon RE, Szrajer L, Holland JF. Usefulness of the nude mouse model in mesothelioma based on a direct patient-xenograft comparison. Cancer. 1991 Aug 1; 68(3):558-60.
      View in: PubMed
    165. Bruckner HW, Cohen C, Mandeli J, Chesser MR, Kabakow B, Wallach R, Holland J. Hexamethylmelamine for the treatment of ovarian cancer--the Mount Sinai experience. Cancer Treat Rev. 1991 Mar; 18 Suppl A:57-65.
      View in: PubMed
    166. Stiefel F, Holland J. Delirium in cancer patients. Int Psychogeriatr. 1991; 3(2):333-6.
      View in: PubMed
    167. Schwartz GK, Arkin H, Holland JF, Ohnuma T. Protein kinase C activity and multidrug resistance in MOLT-3 human lymphoblastic leukemia cells resistant to trimetrexate. Cancer Res. 1991 Jan 1; 51(1):55-61.
      View in: PubMed
    168. Holland J. Cancer and suicide: less common and more predictable than we thought. Ann Oncol. 1991 Jan; 2(1):8.
      View in: PubMed
    169. Roboz J, Kappatos D, Holland JF. Polyol concentrations in serum during hemodialysis. Clin Chem. 1990 Dec; 36(12):2082-6.
      View in: PubMed
    170. Paciucci PA, Davis RB, Holland JF, Martelo O, Schiffer CA. Mitoxantrone and constant infusion etoposide for relapsed and refractory acute myelocytic leukemia. Am J Clin Oncol. 1990 Dec; 13(6):516-9.
      View in: PubMed
    171. Schwartz GK, Redwood SM, Ohnuma T, Holland JF, Droller MJ, Liu BC. Inhibition of invasion of invasive human bladder carcinoma cells by protein kinase C inhibitor staurosporine. J Natl Cancer Inst. 1990 Nov 21; 82(22):1753-6.
      View in: PubMed
    172. Bhardwaj S, Holland JF. A pilot trial of TMM (thiotepa, mitoxantrone and methotrexate) chemotherapy for metastatic breast cancer. Ann Oncol. 1990 Nov; 1(6):443-4.
      View in: PubMed
    173. Addo SB, Holland JF, Kirschenbaum A, Mandeli J, Hollander VP. Serum of patients with prostatic cancer or benign prostatic hypertrophy contains nonpolar testosterone. Steroids. 1990 Nov; 55(11):491-4.
      View in: PubMed
    174. Gottlieb AJ, Anderson JR, Ginsberg SJ, Bloomfield CD, Norton L, Barcos M, Peterson BA, Nissen N, Henderson ES, Holland JF. A randomized comparison of methotrexate dose and the addition of bleomycin to CHOP therapy for diffuse large cell lymphoma and other non-Hodgkin's lymphomas. Cancer and Leukemia Group B study 7851. Cancer. 1990 Nov 1; 66(9):1888-96.
      View in: PubMed
    175. Paciucci PA, Cuttner J, Holland JF. Sequential intermediate-dose cytosine arabinoside and mitoxantrone for patients with relapsed and refractory acute myelocytic leukemia. Am J Hematol. 1990 Sep; 35(1):22-5.
      View in: PubMed
    176. Paciucci PA, Mandeli J, Oleksowicz L, Ameglio F, Holland JF. Thrombocytopenia during immunotherapy with interleukin-2 by constant infusion. Am J Med. 1990 Sep; 89(3):308-12.
      View in: PubMed
    177. Crown JP, Chahinian AP, Jaffrey IS, Glidewell OJ, Kaneko M, Holland JF. Predictors of 5-year survival and curability in small cell lung cancer. Cancer. 1990 Jul 15; 66(2):382-6.
      View in: PubMed
    178. Erickson ED, Enke CG, Holland JF, Watson JT. Application of time array detection to capillary column gas chromatography/conventional time-of-flight mass spectrometry. Anal Chem. 1990 May 15; 62(10):1079-84.
      View in: PubMed
    179. Kane MJ, Chahinian AP, Holland JF. Malignant mesothelioma in young adults. Cancer. 1990 Mar 15; 65(6):1449-55.
      View in: PubMed
    180. Fekete B, Hildreth JE, Holland JF, Bekesi JG. Involvement of lymphocyte function-associated antigen-1 (LFA-1) but not ICAM-1 in a radioactive leukocyte cell-mediated immunity (LA-CMI) assay. J Clin Lab Immunol. 1990 Mar; 31(3):145-9.
      View in: PubMed
    181. Roboz J, Nieves E, Holland JF. Separation and quantification by gas chromatography-mass spectrometry of arabinitol enantiomers to aid the differential diagnosis of disseminated candidiasis. J Chromatogr. 1990 Feb 2; 500:413-26.
      View in: PubMed
    182. Arkin H, Ohnuma T, Kamen BA, Holland JF, Vallabhajosula S. Multidrug resistance in a human leukemic cell line selected for resistance to trimetrexate. Cancer Res. 1989 Dec 1; 49(23):6556-61.
      View in: PubMed
    183. Sridhar KS, Ohnuma T, Nieburgs HE, Duncan RC, Holland JF. Relationship between the in vitro colony growth of human tumors and cytologic diagnosis. Cancer. 1989 Dec 1; 64(11):2275-8.
      View in: PubMed
    184. Bruckner HW, Cohen CJ, Bhardwaj S, Feuer E, Chesser MR, Holland JF. Schedule and dosage modification of a cyclophosphamide, hexamethylmelamine, doxorubicin, cisplatin combination chemotherapy regimen for refractory ovarian cancer. Eur J Cancer Clin Oncol. 1989 Sep; 25(9):1273-9.
      View in: PubMed
    185. Chahinian AP, Propert KJ, Ware JH, Zimmer B, Perry MC, Hirsh V, Skarin A, Kopel S, Holland JF, Comis RL, et al. A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group B. J Clin Oncol. 1989 Aug; 7(8):993-1002.
      View in: PubMed
    186. Paciucci PA, Crown JC, Holland JF. Mitoxantrone, vincristine, and dexamethasone in patients with refractory lymphoma. Am J Clin Oncol. 1989 Aug; 12(4):327-31.
      View in: PubMed
    187. Paciucci PA, Holland JF, Glidewell O, Odchimar R. Recombinant interleukin-2 by continuous infusion and adoptive transfer of recombinant interleukin-2-activated cells in patients with advanced cancer. J Clin Oncol. 1989 Jul; 7(7):869-78.
      View in: PubMed
    188. Roboz J, Chahinian AP, Holland JF, Silides D, Szrajer L. Early diagnosis and monitoring of transplanted human malignant mesothelioma by serum hyaluronic acid. J Natl Cancer Inst. 1989 Jun 21; 81(12):924-8.
      View in: PubMed
    189. Paciucci PA, Holland JF, Ryder JS, Konefal RG, Bekesi GJ, Odchimar R, Gordon R. Immunotherapy with interleukin-2 by constant infusion with and without adoptive cell transfer and with weekly doxorubicin. Cancer Treat Rev. 1989 Jun; 16 Suppl A:67-81.
      View in: PubMed
    190. Bruckner HW, Cohen CJ, Feuer E, Holland JF. Modulation and intensification of a cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin ovarian cancer regimen. Obstet Gynecol. 1989 Mar; 73(3 Pt 1):349-56.
      View in: PubMed
    191. Preisler HD, Anderson K, Rai K, Cuttner J, Yates J, DuPre E, Holland JF. The frequency of long-term remission in patients with acute myelogenous leukaemia treated with conventional maintenance chemotherapy: a study of 760 patients with a minimal follow-up time of 6 years. Br J Haematol. 1989 Feb; 71(2):189-94.
      View in: PubMed
    192. Zinzar S, Ohnuma T, Holland JF. Effects of simultaneous and sequential exposure to granulocytic and monocytic inducers on the choice of differentiation pathway in HL-60 promyelocytic leukemia cells. Leuk Res. 1989; 13(1):23-30.
      View in: PubMed
    193. Paciucci PA, Chesa PG, Fierro MT, Gordon R, Konefal RG, Glidewell O, Holland JF. Pinocchio cells: morphologically atypical immunologically heterogeneous lymphocytes induced by treatment with interleukin 2. Immunol Lett. 1988 Dec; 19(4):313-20.
      View in: PubMed
    194. Kane MJ, Silverman LR, Rand JH, Paciucci PA, Holland JF. Myonecrosis as a complication of the use of epsilon amino-caproic acid: a case report and review of the literature. Am J Med. 1988 Dec; 85(6):861-3.
      View in: PubMed
    195. Sridhar KS, Ohnuma T, Plasse TF, Holland JF. Simultaneous soft agar cloning of ascites and solid tumor specimens from patients with ovarian cancer. Cancer. 1988 Oct 15; 62(8):1577-81.
      View in: PubMed
    196. Roboz J, Nieves E, Holland JF, McCamish M, Smith C. Collisional activation decomposition of actinomycins using tandem mass spectrometry. Biomed Environ Mass Spectrom. 1988 Oct; 16(1-12):67-70.
      View in: PubMed
    197. Kohno N, Ohnuma T, Kaneko M, Holland JF. Interactions of doxorubicin and cis-platin in squamous carcinoma cells in culture. Br J Cancer. 1988 Sep; 58(3):330-4.
      View in: PubMed
    198. Shpall EJ, Jones RB, Holland JF, Bhardwaj S, Paciucci PA, Wilfinger CL, Strashun A. Intensive single-agent mitoxantrone for metastatic breast cancer. J Natl Cancer Inst. 1988 Apr 6; 80(3):204-8.
      View in: PubMed
    199. Kohno N, Ohnuma T, Biller HF, Holland JF. Effects of cisplatin plus fluorouracil vs cisplatin plus cytarabine on head and neck squamous multicellular tumor spheroids. Arch Otolaryngol Head Neck Surg. 1988 Feb; 114(2):157-61.
      View in: PubMed
    200. Hollis PH, Zappulla RA, Spigelman MK, Feuer EJ, Holland JF, Malis LI. Effects of etoposide-induced blood-brain barrier disruption on brain water, intracranial pressure, and cerebral vasomotor tone. Exp Neurol. 1988 Feb; 99(2):428-39.
      View in: PubMed
    201. Perloff M, Lesnick GJ, Korzun A, Chu F, Holland JF, Thirlwell MP, Ellison RR, Carey RW, Leone L, Weinberg V, et al. Combination chemotherapy with mastectomy or radiotherapy for stage III breast carcinoma: a Cancer and Leukemia Group B study. J Clin Oncol. 1988 Feb; 6(2):261-9.
      View in: PubMed
    202. Breitbart W, Holland J. Psychosocial aspects of head and neck cancer. Semin Oncol. 1988 Feb; 15(1):61-9.
      View in: PubMed
    203. Hill CK, Holland J, Chang-Liu CM, Buess EM, Peak JG, Peak MJ. Human epithelial teratocarcinoma cells (P3): radiobiological characterization, DNA damage, and comparison with other rodent and human cell lines. Radiat Res. 1988 Feb; 113(2):278-88.
      View in: PubMed
    204. Kano Y, Ohnuma T, Okano T, Holland JF. Effects of vincristine in combination with methotrexate and other antitumor agents in human acute lymphoblastic leukemia cells in culture. Cancer Res. 1988 Jan 15; 48(2):351-6.
      View in: PubMed
    205. Yagi MJ, Scanlon KJ, Chin SE, Holland JF, Bekesi JG. Multiple transport pathways for L1210 cells: uptake of PTT.119, a bifunctional alkylator with carrier amino acids. Chemotherapy. 1988; 34(3):235-47.
      View in: PubMed
    206. Sklarin NT, Chahinian AP, Feuer EJ, Lahman LA, Szrajer L, Holland JF. Augmentation of activity of cis-diamminedichloroplatinum(II) and mitomycin C by interferon in human malignant mesothelioma xenografts in nude mice. Cancer Res. 1988 Jan 1; 48(1):64-7.
      View in: PubMed
    207. Silver RT, Mick R, Degnan TJ, Holland JF, Cavelli F. Attempted prevention of blast crisis in chronic myeloid leukemia by the use of pulsed doses of cytosine arabinoside and cis-chloronitrosurea during the course of busulfan-maintained remission. Cancer Invest. 1988; 6(3):255-62.
      View in: PubMed
    208. Rogalsky V, Svet-Moldavsky I, Arlin Z, Den T, Holland JF. Fibroblast growth inhibitor. Biomed Pharmacother. 1988; 42(8):547-53.
      View in: PubMed
    209. Houghton PJ, Tharp R, Houghton JA, Holland JF, Bekesi JG. Evaluation of 3-(p-fluorophenyl)-L-alanyl-3-[m-bis-(2-chloroethyl) aminophenyl]-L-alanyl-L-methionine ethyl ester HCl (PTT.119) against xenografts of human rhabdomyosarcoma. Cancer Chemother Pharmacol. 1988; 22(3):201-4.
      View in: PubMed
    210. Tsang PH, Roboz JP, Holland JF, Bekesi JG. Effector lymphocyte response to homologous tumor antigens in various stages of malignant disease as monitored by leukocyte adherence inhibition--cell mediated immunity (LAI-CMI). Immunol Lett. 1988 Jan; 17(1):63-70.
      View in: PubMed
    211. Roboz J, Kappatos DC, Holland JF. Role of individual serum pentitol concentrations in the diagnosis of disseminated visceral candidiasis. Eur J Clin Microbiol. 1987 Dec; 6(6):708-14.
      View in: PubMed
    212. Yagi MJ, Holland JF, Bekesi JG. Tumor necrosis factor enhances murine SL3-3 retrovirus replication. J Clin Lab Immunol. 1987 Nov; 24(3):129-34.
      View in: PubMed
    213. Silver RT, Mick R, Cooper R, Ellison RR, Levy R, Brunner K, Schwartz JM, Holland JF. A comparative study of dibromomannitol and busulfan in the treatment of chronic myeloid leukemia. A study of cancer and leukemia group B. Cancer. 1987 Oct 1; 60(7):1442-8.
      View in: PubMed
    214. Paciucci PA, Keaveney C, Cuttner J, Holland JF. Mitoxantrone, vincristine, and prednisone in adults with relapsed or primarily refractory acute lymphocytic leukemia and terminal deoxynucleotidyl transferase positive blastic phase chronic myelocytic leukemia. Cancer Res. 1987 Oct 1; 47(19):5234-7.
      View in: PubMed
    215. Aisner J, Weinberg V, Perloff M, Weiss R, Perry M, Korzun A, Ginsberg S, Holland JF. Chemotherapy versus chemoimmunotherapy (CAF v CAFVP v CMF each +/- MER) for metastatic carcinoma of the breast: a CALGB study. Cancer and Leukemia Group B. J Clin Oncol. 1987 Oct; 5(10):1523-33.
      View in: PubMed
    216. Perry MC, Kardinal CG, Korzun AH, Ginsberg SJ, Raich PC, Holland JF, Ellison RR, Kopel S, Schilling A, Aisner J, et al. Chemohormonal therapy in advanced carcinoma of the breast: Cancer and Leukemia Group B protocol 8081. J Clin Oncol. 1987 Oct; 5(10):1534-45.
      View in: PubMed
    217. Ackermann BL, Holland JF, Watson JT. Comparison of thermally-assisted fast atom bombardment (TA-FAB) with conventional FAB and EI mass spectrometry for the analysis of the Helminthosporium carbonum mycotoxins. Biomed Environ Mass Spectrom. 1987 Sep; 14(9):501-11.
      View in: PubMed
    218. Sznol M, Ohnuma T, Holland JF. Hepatic toxicity of drugs used for hematologic neoplasia. Semin Liver Dis. 1987 Aug; 7(3):237-56.
      View in: PubMed
    219. Sweeley CC, Holland JF, Towson DS, Chamberlin BA. Interactive and multi-sensory analysis of complex mixtures by an automated gas chromatography system. J Chromatogr. 1987 Jul 24; 399:173-81.
      View in: PubMed
    220. Paciucci PA, Dutcher JP, Cuttner J, Strauman JJ, Wiernik PH, Holland JF. Mitoxantrone and ara-C in previously treated patients with acute myelogenous leukemia. Leukemia. 1987 Jul; 1(7):565-7.
      View in: PubMed
    221. Jones RB, Holland JF, Bhardwaj S, Norton L, Wilfinger C, Strashun A. A phase I-II study of intensive-dose adriamycin for advanced breast cancer. J Clin Oncol. 1987 Feb; 5(2):172-7.
      View in: PubMed
    222. Kohno N, Ohnuma T, Holland JF, Biller H. Effects of anticancer agents on the shedding of cells from human multicellular tumor spheroids. Invasion Metastasis. 1987; 7(5):264-74.
      View in: PubMed
    223. Holland JF. Adjuvant chemotherapy of osteosarcoma: no runs, no hits, two men left on base. J Clin Oncol. 1987 Jan; 5(1):4-6.
      View in: PubMed
    224. Williams CK, Cuttner J, Ohnuma T, Ambinder EP, Ferreira PP, Holland JF. Iatrogenic and idiopathic acute myelogenous leukemia: a comparison of clinical features and treatment complications. Med Oncol Tumor Pharmacother. 1987; 4(2):59-66.
      View in: PubMed
    225. Bruckner HW, Cohen CJ, Feuer E, Wallach RC, Kabakow B, Holland JF. Prognostic factors: cisplatin regimens for patients with ovarian cancer after failure of chemotherapy. Obstet Gynecol. 1987 Jan; 69(1):114-20.
      View in: PubMed
    226. Rai KR, Cuttner J, Holland JF, Davis R, Mayer R, McIntyre OR, Preisler H, Yates J. Therapeutic strategies in acute myelocytic leukemia: a status report of the experience of CALGB. Cancer and Leukemia Group B. Haematol Blood Transfus. 1987; 30:31-4.
      View in: PubMed
    227. Inoue S, Ohnuma T, Takaoka K, Suzuki Y, Kaneko M, Safirstein R, Holland JF. Effects of doxorubicin and cisplatin on multicellular tumor spheroids from human lung cancer. Cancer Drug Deliv. 1987; 4(4):213-24.
      View in: PubMed
    228. Ginsberg SJ, Anderson JR, Gottlieb AJ, Bloomfield CD, Norton L, Barcos M, Holland JF. A randomized trial of high-dose methotrexate versus standard-dose methotrexate following cyclophosphamide, doxorubicin (adriamycin), vincristine, and prednisone with or without bleomycin in the therapy of diffuse large cell lymphoma: preliminary report of Cancer and Leukemia Group B Study 7851. NCI Monogr. 1987; (5):77-80.
      View in: PubMed
    229. Wadler S, Chahinian P, Slater W, Goldman M, Mendelson D, Holland JF. Cardiac abnormalities in patients with diffuse malignant pleural mesothelioma. Cancer. 1986 Dec 15; 58(12):2744-50.
      View in: PubMed
    230. Brecher ML, Weinberg V, Boyett JM, Sinks LF, Jones B, Glicksman A, Holland JF, Freeman AI. Intermediate dose methotrexate in childhood acute lymphoblastic leukemia resulting in decreased incidence of testicular relapse. Cancer. 1986 Sep 1; 58(5):1024-8.
      View in: PubMed
    231. Ohnuma T, Arkin H, Holland JF. Effects of cell density on drug-induced cell kill kinetics in vitro (inoculum effect). Br J Cancer. 1986 Sep; 54(3):415-21.
      View in: PubMed
    232. Kano Y, Ohnuma T, Holland JF. Folate requirements of methotrexate-resistant human acute lymphoblastic leukemia cell lines. Blood. 1986 Aug; 68(2):586-91.
      View in: PubMed
    233. Shpall EJ, Holland JF. Update on understanding the causes of cancer. Compr Ther. 1986 Aug; 12(8):9-14.
      View in: PubMed
    234. Holland JF, Leary JJ, Sweeley CC. Advanced instrumentation and strategies for metabolic profiling. J Chromatogr. 1986 Jun 20; 379:3-26.
      View in: PubMed
    235. Vinciguerra V, Propert KJ, Coleman M, Anderson JR, Stutzman L, Pajak TF, Nissen NI, Frizzera G, Gottlieb A, Holland JF. Alternating cycles of combination chemotherapy for patients with recurrent Hodgkin's disease following radiotherapy. A prospectively randomized study by the Cancer and Leukemia Group B. J Clin Oncol. 1986 Jun; 4(6):838-46.
      View in: PubMed
    236. Lew F, Tsang P, Holland JF, Warner N, Selikoff IJ, Bekesi JG. High frequency of immune dysfunctions in asbestos workers and in patients with malignant mesothelioma. J Clin Immunol. 1986 May; 6(3):225-33.
      View in: PubMed
    237. Cohen SM, Ohnuma T, Ambinder EP, Holland JF. Lomustine, bleomycin, and cisplatin in patients with metastatic malignant melanoma. Cancer Treat Rep. 1986 May; 70(5):688-9.
      View in: PubMed
    238. Hollis PH, Zappulla RA, Spigelman MK, Feuer EJ, Johnson J, Holland JF, Malis LI. Physiological and electrophysiological consequences of etoposide-induced blood-brain barrier disruption. Neurosurgery. 1986 May; 18(5):581-6.
      View in: PubMed
    239. Martin DS, Balis ME, Fisher B, Frei E, Freireich EJ, Heppner GH, Holland JF, Houghton JA, Houghton PJ, Johnson RK, et al. Role of murine tumor models in cancer treatment research. Cancer Res. 1986 Apr; 46(4 Pt 2):2189-92.
      View in: PubMed
    240. Spigelman MK, Zappulla RA, Strauchen JA, Feuer EJ, Johnson J, Goldsmith SJ, Malis LI, Holland JF. Etoposide induced blood-brain barrier disruption in rats: duration of opening and histological sequelae. Cancer Res. 1986 Mar; 46(3):1453-7.
      View in: PubMed
    241. Yagi MJ, Maldarelli F, Chin SE, Holland JF, Bekesi JG. Interference of mouse mammary tumor virus replication by PTT.119 [p-fluoro-L-phe-m-bis-(2-chloroethyl)amino-L-phe-met ethoxy HCl]--an antitumor agent. J Natl Cancer Inst. 1986 Mar; 76(3):493-501.
      View in: PubMed
    242. Yu PP, Waxman JS, Chahinian AP, Efremidis AP, Holland JF. Acute myelogenous leukemia following complete remission of small cell carcinoma of the lung. Med Pediatr Oncol. 1986; 14(2):100-3.
      View in: PubMed
    243. Fountzilas G, Ohnuma T, Rammos K, Mindich B, Holland JF. Comparison of mitoxantrone and ametantrone in human acute myelocytic leukemia cells in culture and in bone marrow granulocyte-macrophage progenitor cells. Cancer Drug Deliv. 1986; 3(2):93-100.
      View in: PubMed
    244. Davis RP, Zappulla RA, Spigelman MK, Feuer EJ, Malis LI, Holland JF. The protective effect of experimental subarachnoid haemorrhage on sodium dehydrocholate-induced blood-brain barrier disruption. Acta Neurochir (Wien). 1986; 83(3-4):138-43.
      View in: PubMed
    245. Efremidis AP, Haubenstock HS, Papadopoulos NM, Holland JF, Bekesi JG. Secretory leukemic B cells express T cell markers in vitro. A phenomenon suppressed by TPA. J Immunopharmacol. 1986; 8(2):129-44.
      View in: PubMed
    246. Ackermann BL, Watson JT, Holland JF. Thermally assisted fast atom bombardment: a new approach toward optimization of analyses by fast atom bombardment mass spectrometry. Anal Chem. 1985 Nov; 57(13):2656-63.
      View in: PubMed
    247. Efremidis AP, Haubenstock H, Holland JF, Bekesi JG. Tpa-induced maturation in secretory human B-leukemic cells in vitro: DNA synthesis, antigenic changes, and immunoglobulin secretion. Blood. 1985 Oct; 66(4):953-60.
      View in: PubMed
    248. Leyvraz S, Ohnuma T, Lassus M, Holland JF. Phase 1 study of carboplatin in patients with advanced cancer, intermittent intravenous bolus, and 24-hour infusion. J Clin Oncol. 1985 Oct; 3(10):1385-92.
      View in: PubMed
    249. Wood WC, Weiss RB, Tormey DC, Holland JF, Henry PH, Leone LA, Rafla S, Silver RT, Carey RW, Lesnick GJ, et al. A randomized trial of CMF versus CMFVP as adjuvant chemotherapy in women with node-positive stage II breast cancer: a CALGB Study. World J Surg. 1985 Oct; 9(5):714-8.
      View in: PubMed
    250. Holland JF. Randomized trials in rare tumors. J Clin Oncol. 1985 Sep; 3(9):1163-5.
      View in: PubMed
    251. Zinzar SN, Den T, Holland JF. Mononuclear macrophage (M-CFC) colony formation in semisolid media in the absence of exogenous GM-CSF. J Cell Physiol. 1985 Sep; 124(3):457-66.
      View in: PubMed
    252. Shafir M, Holland JF, Cohen B, Aufses AH. Radical retroperitoneal tumor surgery with resection of the psoas major muscle. Cancer. 1985 Aug 15; 56(4):929-33.
      View in: PubMed
    253. Schindler M, Allen ML, Olinger MR, Holland JF. Automated analysis and survival selection of anchorage-dependent cells under normal growth conditions. Cytometry. 1985 Jul; 6(4):368-74.
      View in: PubMed
    254. Yagi MJ, Chin SE, Scanlon KJ, Holland JF, Bekesi JG. PTT.119, p-F-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met ethoxy HCl, a new chemotherapeutic agent active against drug-resistant tumor cell lines. Biochem Pharmacol. 1985 Jul 1; 34(13):2347-54.
      View in: PubMed
    255. Zinzar SN, Svet-Moldavsky GJ, Fogh J, Mann PE, Arlin Z, Iliescu K, Holland JF. Elaboration of granulocyte-macrophage colony-stimulating factor by human tumor cell lines and normal urothelium. Exp Hematol. 1985 Jul; 13(6):574-80.
      View in: PubMed
    256. Fónagy A, Antal S, Holland J, Körösi L, Hidvégi EJ. Inhibition of protein synthesis in developing mouse brain after fission neutron irradiation in utero. Radiat Res. 1985 Jul; 103(1):34-45.
      View in: PubMed
    257. Perlow L, Ohnuma T, Andrejczuk A, Shafir M, Strauchen J, Holland JF. Pharmacology and toxicology of a seven-day infusion of 1-beta-D-arabinofuranosylcytosine plus uridine in dogs. Cancer Res. 1985 Jun; 45(6):2572-7.
      View in: PubMed
    258. Sridhar KS, Holland JF, Brown JC, Cohen JM, Ohnuma T. Doxorubicin plus cisplatin in the treatment of apudomas. Cancer. 1985 Jun 1; 55(11):2634-7.
      View in: PubMed
    259. Leyvraz S, Henle W, Chahinian AP, Perlmann C, Klein G, Gordon RE, Rosenblum M, Holland JF. Association of Epstein-Barr virus with thymic carcinoma. N Engl J Med. 1985 May 16; 312(20):1296-9.
      View in: PubMed
    260. Ohnuma T, Holland JF. Homoharringtonine as a new antileukemic agent. J Clin Oncol. 1985 May; 3(5):604-6.
      View in: PubMed
    261. Hurny C, Holland J. Psychosocial sequelae of ostomies in cancer patients. CA Cancer J Clin. 1985 May-Jun; 35(3):170-83.
      View in: PubMed
    262. Roboz J, Greaves J, Silides D, Chahinian AP, Holland JF. Hyaluronic acid content of effusions as a diagnostic aid for malignant mesothelioma. Cancer Res. 1985 Apr; 45(4):1850-4.
      View in: PubMed
    263. Ohnuma T, Lo RJ, Scanlon KJ, Kamen BA, Ohnoshi T, Wolman SR, Holland JF. Evolution of methotrexate resistance of human acute lymphoblastic leukemia cells in vitro. Cancer Res. 1985 Apr; 45(4):1815-22.
      View in: PubMed
    264. Wong B, Bernard EM, Armstrong D, Roboz J, Suzuki R, Holland JF. Evaluation of the aldononitrile peracetate method for measuring arabinitol in serum. J Clin Microbiol. 1985 Mar; 21(3):478-9.
      View in: PubMed
    265. Roboz J, Greaves J, McCamish M, Holland JF, Bekesi G. An in vitro model for the binding of polybrominated biphenyls in environmentally contaminated blood. Arch Environ Contam Toxicol. 1985 Mar; 14(2):137-42.
      View in: PubMed
    266. Tsang PH, Holland JF, Bekesi JG. Tumor-associated immunity and serum blocking by radioisotopic leukocyte adherence inhibition assay. Mt Sinai J Med. 1985 Mar; 52(3):193-200.
      View in: PubMed
    267. Holland JF. Cancer surgery: the view from cancer medicine. Mt Sinai J Med. 1985 Mar; 52(3):159-60.
      View in: PubMed
    268. Ohnoshi T, Ohnuma T, Beranek JT, Holland JF. Combined cytotoxicity effect of hyperthermia and anthracycline antibiotics on human tumor cells. J Natl Cancer Inst. 1985 Feb; 74(2):275-81.
      View in: PubMed
    269. Sridhar KS, Ohnuma T, Biller H, Holland JF, Ambinder EP, Barba J. Combination chemotherapy with high-dose methotrexate, bleomycin, and cisplatin in management of head and neck squamous cell carcinoma. Am J Clin Oncol. 1985 Feb; 8(1):55-60.
      View in: PubMed
    270. Ohnuma T, Norton L, Andrejczuk A, Holland JF. Pharmacokinetics of vindesine given as an intravenous bolus and 24-hour infusion in humans. Cancer Res. 1985 Jan; 45(1):464-9.
      View in: PubMed
    271. Roboz J, Greaves J, Yagi MJ, Holland JF, Bekesi JG. Analytical and pharmacological studies on a new antineoplastic tripeptide, PTT.119. Pharmacology. 1985; 30(1):52-9.
      View in: PubMed
    272. Takemura Y, Ohnuma T, Chou TC, Okano T, Holland JF. Biologic and pharmacologic effects of harringtonine on human leukemia-lymphoma cells. Cancer Chemother Pharmacol. 1985; 14(3):206-10.
      View in: PubMed
    273. Sun AS, Holland JF. Implications of 5'-nucleotidase and its inhibitor for cellular aging and cancer. Basic Life Sci. 1985; 35:163-80.
      View in: PubMed
    274. Roboz J, Kappatos DC, Greaves J, Holland JF. Determination of polyols in serum by selected ion monitoring. Clin Chem. 1984 Oct; 30(10):1611-5.
      View in: PubMed
    275. Spigelman MK, Zappulla RA, Johnson J, Goldsmith SJ, Malis LI, Holland JF. Etoposide-induced blood-brain barrier disruption. Effect of drug compared with that of solvents. J Neurosurg. 1984 Oct; 61(4):674-8.
      View in: PubMed
    276. Chahinian AP, Green G, Holland JF. Mitomycin-C, etoposide, cisplatin, and hexamethylmelamine (MEPH) as a second-line regimen in lung cancer. Am J Clin Oncol. 1984 Oct; 7(5):419-23.
      View in: PubMed
    277. Goldsmith MA, Ohnuma T, Jaffrey IH, Greenspan EM, Holland JF. Phase I study of mitoxantrone on a daily X 5 schedule. Am J Clin Oncol. 1984 Oct; 7(5):567-70.
      View in: PubMed
    278. Paciucci PA, Cuttner J, Holland JF. Mitoxantrone as a single agent and in combination chemotherapy in patients with refractory acute leukemia. Semin Oncol. 1984 Sep; 11(3 Suppl 1):36-40.
      View in: PubMed
    279. Cooper MR, Pajak TF, Gottlieb AJ, Glicksman AS, Nissen N, Richards F, Bloomfield C, Holland JF. The effects of prior radiation therapy and age on the frequency and duration of complete remission among various four-drug treatments for advanced Hodgkin's disease. J Clin Oncol. 1984 Jul; 2(7):748-55.
      View in: PubMed
    280. Himori T, Ohnuma T, Holland JF. Chemotherapeutic susceptibility of human bone marrow progenitor cells and human myelogenous leukemia cells (HL-60) in co-culture: preliminary report. Int J Cell Cloning. 1984 Jul; 2(4):254-62.
      View in: PubMed
    281. Rhodes SB, Frantz WL, Holland J. The effects of iodination on the receptor binding affinity of ovine prolactin. Biochem Biophys Res Commun. 1984 Jun 15; 121(2):686-94.
      View in: PubMed
    282. Amrein PC, Poulin RF, Coleman M, Richards F, Weil M, Kennedy BJ, Carey RW, Green MR, Holland JF, Weinberg V, et al. The treatment of melanoma with m-AMSA. A Cancer and Leukemia Group B phase II study. Am J Clin Oncol. 1984 Jun; 7(3):269-71.
      View in: PubMed
    283. Amrein PC, Richards F, Coleman M, Poulin RF, Holland JF, Weinberg V, Perry M. Phase II trial of amsacrine in patients with hepatoma: a Cancer and Leukemia Group B study. Cancer Treat Rep. 1984 Jun; 68(6):923-4.
      View in: PubMed
    284. Chahinian AP, Norton L, Holland JF, Szrajer L, Hart RD. Experimental and clinical activity of mitomycin C and cis-diamminedichloroplatinum in malignant mesothelioma. Cancer Res. 1984 Apr; 44(4):1688-92.
      View in: PubMed
    285. Slankard-Chahinian M, Holland JF, Gordon RE, Becker J, Ohnuma T. Adoptive autoimmunotherapy. Cytotoxic effect of an autologous long-term T-cell line on malignant melanoma. Cancer. 1984 Mar 1; 53(5):1066-72.
      View in: PubMed
    286. Plasse TF, Ohnuma T, Brooks S, Saponaro E, Holland JF, Biller H. Bleomycin infusion followed by cyclophosphamide, methotrexate, and 5-fluorouracil in advanced squamous carcinoma of the head and neck. Cancer. 1984 Feb 15; 53(4):841-3.
      View in: PubMed
    287. Perlow LS, Holland JF. Chemotherapy of breast cancer. Med Oncol Tumor Pharmacother. 1984; 1(3):169-92.
      View in: PubMed
    288. Yagi MJ, Zanjani M, Holland JF, Bekesi JG. Increased cancericidal activity of PTT.119; a new synthetic bis-(2-chloroethyl)amino-L-phenylalanine derivative with carrier amino acids. II. In vivo bioassay. Cancer Chemother Pharmacol. 1984; 12(2):77-82.
      View in: PubMed
    289. Roboz J, Paciucci PA, Silides D, Greaves J, Holland JF. Detection and quantification of mitoxantrone in human organs. A case report. Cancer Chemother Pharmacol. 1984; 13(1):67-8.
      View in: PubMed
    290. Spigelman MK, Zappulla RA, Goldberg JD, Goldsmith SJ, Marotta D, Malis LI, Holland JF. Effect of intracarotid etoposide on opening the blood-brain barrier. Cancer Drug Deliv. 1984; 1(3):207-11.
      View in: PubMed
    291. Beranek JT, Ohnuma T, Takahashi I, Minowada J, Holland JF. Chemotherapeutic sensitivity of acute lymphoblastic leukemia cells in culture: correlation with clinical efficacy on donor patients. Cancer Drug Deliv. 1984; 1(4):307-19.
      View in: PubMed
    292. Yagi MJ, Bekesi JG, Daniel MD, Holland JF, De Barbieri A. Increased cancericidal activity of PTT.119, a new synthetic bis-(2-chloroethyl)amino-L-phenylalanine derivative with carrier amino acids. I. In vitro cytotoxicity. Cancer Chemother Pharmacol. 1984; 12(2):70-6.
      View in: PubMed
    293. Okano T, Ohnuma T, Efremidis A, Holland JF. Doxorubicin-induced skin ulcer in the piglet. Cancer Treat Rep. 1983 Dec; 67(12):1075-8.
      View in: PubMed
    294. Paciucci PA, Ohnuma T, Cuttner J, Silver RT, Holland JF. Mitoxantrone in acute lymphoblastic leukemia. Cancer Treat Rev. 1983 Dec; 10 Suppl B:65-8.
      View in: PubMed
    295. Holland JF. Mitoxantrone--a critique. Cancer Treat Rev. 1983 Dec; 10 Suppl B:77-9.
      View in: PubMed
    296. Chahinian AP, Holland JF, Bhardwaj S. Chemotherapy for malignant thymoma. Ann Intern Med. 1983 Nov; 99(5):736.
      View in: PubMed
    297. Cohen SM, Ohnuma T, Cheung T, Holland JF. Bleomycin, carmustine, vincristine, and dacarbazine in patients with metastatic malignant melanoma. Cancer Treat Rep. 1983 Oct; 67(10):947-8.
      View in: PubMed
    298. Sridhar KS, Plasse TF, Holland JF, Shapiro M, Ohnuma T. Effects of physiological oxygen concentration on human tumor colony growth in soft agar. Cancer Res. 1983 Oct; 43(10):4629-31.
      View in: PubMed
    299. Cohen CJ, Bruckner HW, Goldberg JD, Holland JF. Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO III and IV) as measured by surgical end-staging (second-look surgery)--the mount sinai experience. Clin Obstet Gynaecol. 1983 Aug; 10(2):307-24.
      View in: PubMed
    300. Svet-Moldavskaya IA, Zinzar SN, Svet-Moldavsky GJ, Arlin Z, Vergara C, Koziner B, Clarkson BD, Holland JF. Phenomenon of formation of giant fat-containing cells in human bone marrow cultures induced by human serum factor: normal and leukemic patterns. Proc Natl Acad Sci U S A. 1983 Aug; 80(15):4847-50.
      View in: PubMed
    301. Paciucci PA, Ohnuma T, Cuttner J, Silver RT, Holland JF. Mitoxantrone in patients with acute leukemia in relapse. Cancer Res. 1983 Aug; 43(8):3919-22.
      View in: PubMed
    302. Sun AS, Holland JF, Lin K, Ohnuma T. Implications of a 5'-nucleotidase inhibitor in human leukemic cells for cellular aging and cancer. Biochim Biophys Acta. 1983 Jul 14; 762(4):577-84.
      View in: PubMed
    303. Chahinian AP, Kirschner PA, Dikman SH, Rammos KS, Holland JF. Pulmonary metastatic leiomyosarcoma coexisting with pulmonary chondroma in Carney's triad. Arch Intern Med. 1983 Jul; 143(7):1462-4.
      View in: PubMed
    304. Sridhar KS, Ohnuma T, Chahinian AP, Holland JF. Phase I study of acivicin in patients with advanced cancer. Cancer Treat Rep. 1983 Jul-Aug; 67(7-8):701-3.
      View in: PubMed
    305. Conjalka MS, Cuttner J, Wisniewski L, Goldberg JD, Reisman A, Elliott R, Desnick R, Holland JF, Berk PD. Pretreatment marrow cytogenetic status: a predictor of response to remission induction therapy in acute myelogenous leukemia. Mt Sinai J Med. 1983 May-Jun; 50(3):201-7.
      View in: PubMed
    306. Cohen CJ, Goldberg JD, Holland JF, Bruckner HW, Deppe G, Gusberg SB, Wallach RC, Kabakow B, Rodin J. Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO Stages III and IV) as measured by surgical end-staging (second-look operation). Am J Obstet Gynecol. 1983 Apr 15; 145(8):955-67.
      View in: PubMed
    307. Bruckner HW, Cohen CJ, Goldberg JD, Kabakow B, Wallach RC, Deppe G, Reisman AZ, Gusberg SB, Holland JF. Cisplatin regimens and improved prognosis of patients with poorly differentiated ovarian cancer. Am J Obstet Gynecol. 1983 Mar 15; 145(6):653-8.
      View in: PubMed
    308. Freeman AI, Weinberg V, Brecher ML, Jones B, Glicksman AS, Sinks LF, Weil M, Pleuss H, Hananian J, Burgert EO, Gilchrist GS, Necheles T, Harris M, Kung F, Patterson RB, Maurer H, Leventhal B, Chevalier L, Forman E, Holland JF. Comparison of intermediate-dose methotrexate with cranial irradiation for the post-induction treatment of acute lymphocytic leukemia in children. N Engl J Med. 1983 Mar 3; 308(9):477-84.
      View in: PubMed
    309. Tormey DC, Weinberg VE, Holland JF, Weiss RB, Glidewell OJ, Perloff M, Falkson G, Falkson HC, Henry PH, Leone LA, et al. A randomized trial of five and three drug chemotherapy and chemoimmunotherapy in women with operable node positive breast cancer. J Clin Oncol. 1983 Feb; 1(2):138-45.
      View in: PubMed
    310. Holland JF. Karnofsky Memorial Lecture. Breaking the cure barrier. J Clin Oncol. 1983 Feb; 1(2):75-90.
      View in: PubMed
    311. Goldsmith MA, Ohnuma T, Spigelman M, Greenspan EM, Holland JF. Phase I study of L-alanosine (NSC 15353). Cancer. 1983 Feb 1; 51(3):378-80.
      View in: PubMed
    312. Cuttner J, Holland JF, Norton L, Ambinder E, Button G, Meyer RJ. Therapeutic leukapheresis for hyperleukocytosis in acute myelocytic leukemia. Med Pediatr Oncol. 1983; 11(2):76-8.
      View in: PubMed
    313. Okano T, Ohnuma T, Holland JF, Koeffler HP, Jui H. Effects of harringtonine in combination with acivicin, adriamycin, L-asparaginase, cytosine arabinoside, dexamethasone, fluorouracil or methotrexate on human acute myelogenous leukemia cell line KG-1. Invest New Drugs. 1983; 1(2):145-50.
      View in: PubMed
    314. Paciucci PA, Holland JF. Hypothesis: AIDS: AAIDS (acquired autoimmune immunodeficiency syndrome)? AIDS Res. 1983-1984; 1(2):149-55.
      View in: PubMed
    315. Svet-Moldavsky GJ, Svet-Moldavsky IA, Zinzar SN, Iliescu K, Reilly M, Sulinski C, Holland JF. The properties of human fetal bone marrow stromal and hemopoietic cells. Biomed Pharmacother. 1983; 37(5):218-21.
      View in: PubMed
    316. Tsang PH, Holland JF, Bekesi JG. Specificity of tumor antigen recognition by T-lymphocytes in the leukocyte adherence inhibition (LAI) assay in patients with breast cancer. J Clin Lab Immunol. 1982 Dec; 9(3):151-7.
      View in: PubMed
    317. Roboz J, Greaves J, Jui H, Holland JF. Quantification of homoharringtonine and harringtonine in serum by chemical ionization mass spectrometry. Biomed Mass Spectrom. 1982 Dec; 9(12):510-4.
      View in: PubMed
    318. Tsang PH, Holland JF, Bekesi JG. Central role of T lymphocytes in specific recognition of tumor antigens in 51Cr-leukocyte adherence inhibition. Cell Immunol. 1982 Nov 1; 73(2):365-75.
      View in: PubMed
    319. Jones KG, Holland JF, Fouts JR. Benzo(a)pyrene hydroxylase activity in enriched populations of Clara cells and alveolar type II cells from control and beta-naphthoflavone-pretreated rats. Cancer Res. 1982 Nov; 42(11):4658-63.
      View in: PubMed
    320. Keusch GT, Ambinder EP, Kovacs I, Goldberg JD, Phillips DM, Holland JF. Role of opsonins in clinical response to granulocyte transfusion in granulocytopenic patients. Am J Med. 1982 Oct; 73(4):552-63.
      View in: PubMed
    321. Bhardwaj S, Holland JF. Chemotherapy of metastatic cancer in bone. Clin Orthop Relat Res. 1982 Sep; (169):28-37.
      View in: PubMed
    322. Yates J, Glidewell O, Wiernik P, Cooper MR, Steinberg D, Dosik H, Levy R, Hoagland C, Henry P, Gottlieb A, Cornell C, Berenberg J, Hutchison JL, Raich P, Nissen N, Ellison RR, Frelick R, James GW, Falkson G, Silver RT, Haurani F, Green M, Henderson E, Leone L, Holland JF. Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study. Blood. 1982 Aug; 60(2):454-62.
      View in: PubMed
    323. Roboz J, Richardson CL, Holland JF. Comparison of the interaction of antineoplastic aminoanthraquinone analogs with DNA using competitive fluorescence polarization. Life Sci. 1982 Jul 5; 31(1):25-30.
      View in: PubMed
    324. Plasse T, Ohnuma T, Bruckner H, Chamberlain K, Mass T, Holland JF. Portable infusion pumps in ambulatory cancer chemotherapy. Cancer. 1982 Jul 1; 50(1):27-31.
      View in: PubMed
    325. Ohnuma T, Sridhar KS, Ratner LH, Holland JF. Phase I study of indicine N-oxide in patients with advanced cancer. Cancer Treat Rep. 1982 Jul; 66(7):1509-15.
      View in: PubMed
    326. Borden EC, Holland JF, Dao TL, Gutterman JU, Wiener L, Chang YC, Patel J. Leukocyte-derived interferon (alpha) in human breast carcinoma. The American Cancer Society phase II trial. Ann Intern Med. 1982 Jul; 97(1):1-6.
      View in: PubMed
    327. Roboz J, Greaves J, Holland JF, Bekesi JG. Determination of polybrominated biphenyls in serum by negative chemical ionization mass spectrometry. Anal Chem. 1982 Jun; 54(7):1104-8.
      View in: PubMed
    328. Cooper MR, Pajak TF, Nissen NI, Brunner K, Stutzman L, Bank A, Falkson G, Barker BE, Haurani FI, Richards F, Gottlieb A, Holland JF. Effect of methanol extraction residue of Bacillus Calmette-Guerin in advanced Hodgkin's disease. Cancer. 1982 Jun 1; 49(11):2226-30.
      View in: PubMed
    329. Chahinian AP, Pajak TF, Holland JF, Norton L, Ambinder RM, Mandel EM. Diffuse malignant mesothelioma. Prospective evaluation of 69 patients. Ann Intern Med. 1982 Jun; 96(6 Pt 1):746-55.
      View in: PubMed
    330. Chahinian AP, Goldberg J, Holland JF, Reisman A, Jaffrey IS, Mandel EM. Chemotherapy versus chemoimmunotherapy with levamisole or Corynebacterium parvum in advanced lung cancer. Cancer Treat Rep. 1982 Jun; 66(6):1291-7.
      View in: PubMed
    331. Ohnoshi T, Ohnuma T, Takahashi I, Scanlon K, Kamen BA, Holland JF. Establishment of methotrexate-resistant human acute lymphoblastic leukemia cells in culture and effects of folate antagonists. Cancer Res. 1982 May; 42(5):1655-60.
      View in: PubMed
    332. Vrbanac JJ, Braselton WE, Holland JF, Sweeley CC. Automated qualitative and quantitative metabolic profiling analysis of urinary steroids by a gas chromatography-mass spectrometry-data system. J Chromatogr. 1982 Apr 30; 239:265-76.
      View in: PubMed
    333. Bloomfield CD, Pajak TF, Glicksman AS, Gottlieb AJ, Coleman M, Nissen NI, Rafla S, Stutzman L, Vinciguerra V, Glidewell OJ, Holland JF. Chemotherapy and combined modality therapy for Hodgkin's disease: a progress report on Cancer and Leukemia Group B studies. Cancer Treat Rep. 1982 Apr; 66(4):835-46.
      View in: PubMed
    334. Peterson BA, Pajak TF, Cooper MR, Nissen NI, Glidewell OJ, Holland JF, Bloomfield CD, Gottlieb AJ. Effect of age on therapeutic response and survival in advanced Hodgkin's disease. Cancer Treat Rep. 1982 Apr; 66(4):889-98.
      View in: PubMed
    335. Kyle RA, Pajak TF, Henderson ES, Nawabi IU, Brunner K, Henry PH, McIntyre OR, Holland JF. Multiple myeloma resistant to melphalan: treatment with doxorubicin, cyclophosphamide, carmustine (BCNU), and prednisone. Cancer Treat Rep. 1982 Mar; 66(3):451-6.
      View in: PubMed
    336. Sun AS, Holland JF, Ohnuma T, Slankard-Chahinian M. 5'-nucleotidase activity in permanent human lymphoid cell lines. Implication for cell proliferation and aging in vitro. Biochim Biophys Acta. 1982 Feb 25; 714(3):530-5.
      View in: PubMed
    337. Hart RD, Ohnuma T, Holland JF, Bruckner H. Methyl-GAG in patients with malignant neoplasms: a phase I re-evaluation. Cancer Treat Rep. 1982 Jan; 66(1):65-71.
      View in: PubMed
    338. Williams CK, Fernbach B, Cuttner J, Holland JF, Essien EM. Management of leukaemia-associated disseminated intravascular coagulation (DIC). Haematologia (Budap). 1982; 15(3):287-95.
      View in: PubMed
    339. Zumoff B, Gorzynski JG, Katz JL, Weiner H, Levin J, Holland J, Fukushima DK. Nonobesity at the time of mastectomy is highly predictive of 10-year disease-free survival in women with breast cancer. Anticancer Res. 1982 Jan-Apr; 2(1-2):59-62.
      View in: PubMed
    340. Bekesi JG, Holland JF. Therapeutic effectiveness of neuraminidase-treated allogeneic myeloblasts as immunogen in acute myelocytic leukemia. Recent Results Cancer Res. 1982; 80:42-55.
      View in: PubMed
    341. Rai KR, Holland JF, Glidewell OJ, Weinberg V, Brunner K, Obrecht JP, Preisler HD, Nawabi IW, Prager D, Carey RW, Cooper MR, Haurani F, Hutchison JL, Silver RT, Falkson G, Wiernik P, Hoagland HC, Bloomfield CD, James GW, Gottlieb A, Ramanan SV, Blom J, Nissen NI, Bank A, Ellison RR, Kung F, Henry P, McIntyre OR, Kaan SK. Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B. Blood. 1981 Dec; 58(6):1203-12.
      View in: PubMed
    342. Cortes EP, Holland JF. Adjuvant chemotherapy for primary osteogenic sarcoma. Surg Clin North Am. 1981 Dec; 61(6):1391-404.
      View in: PubMed
    343. Holland JF. Adjuvant chemotherapy for breast cancer. Surg Clin North Am. 1981 Dec; 61(6):1361-70.
      View in: PubMed
    344. Nir Y, Pynoos RS, Holland J. Cancer in a parent: the impact on mother and child. A consultation-liaison clinical case conference. Gen Hosp Psychiatry. 1981 Dec; 3(4):337-42.
      View in: PubMed
    345. Svet-Moldavskaya IA, Arlin Z, Svet-Moldavsky GJ, Clarkson BD, Koziner B, Mendelsohn N, Zinzar SN, Holland JF. Induction by tumor-promoting phorbol diester of colony-stimulating activity in human myeloid leukemia cells transformed to macrophage-mimicking cells. Cancer Res. 1981 Nov; 41(11 Pt 1):4335-40.
      View in: PubMed
    346. Cavalli F, Jungi WF, Nissen NI, Pajak TF, Coleman M, Holland JF. Phase II trial of cis-dichlorodiammineplatinum (II) in advanced malignant lymphoma: a study of the cancer and acute leukemia group B. Cancer. 1981 Nov 1; 48(9):1927-30.
      View in: PubMed
    347. Holland JF. Cancer in the aged. Mt Sinai J Med. 1981 Nov-Dec; 48(6):496-9.
      View in: PubMed
    348. Svet-Moldavsky I, Svet-Moldavsky G, Zinzar S, Holland J, Vergara C, Arlin Z, Koziner B, Clarkson B. The extracerebral dopamine antagonist domperidone block the suppressive effect of bromocriptine on prolactin and TSH secretion in man. Biomedicine. 1981 Oct; 35(5):142-4.
      View in: PubMed
    349. Hart RD, Perloff M, Holland JF. One-day VATH (vinblastine, Adriamycin, thiotepa, and Halotestin) therapy for advanced breast cancer refractory to chemotherapy. Cancer. 1981 Oct 1; 48(7):1522-7.
      View in: PubMed
    350. Svet-Moldavskaya IA, Svet-Moldavsky GJ, Zinzar SN, Holland JF, Vergara C, Arlin Z, Koziner B, Clarkson BD. Induction of giant fat cells in human bone marrow culture by human serum factor. Biomedicine. 1981 Oct; 35(5):141-2.
      View in: PubMed
    351. Bruckner HW, Cohen CJ, Deppe G, Kabakow B, Wallach R, Ratner L, Holland JF. Treatment of chemotherapy-resistant advanced ovarian cancer with a combination of cyclophosphamide, hexamethylmelamine, adriamycin, and cis-diamminedichloroplatinum (CHAP). Gynecol Oncol. 1981 Oct; 12(2 Pt 1):150-3.
      View in: PubMed
    352. Chahinian AP, Holland JF, Nieburgs HE, Marinescu A, Geller SA, Kirschner PA. Metastatic nonfunctioning parathyroid carcinoma: ultrastructural evidence of secretory granules and response to chemotherapy. Am J Med Sci. 1981 Sep-Oct; 282(2):80-4.
      View in: PubMed
    353. Bruckner HW, Wallach R, Cohen CJ, Deppe G, Kabakow B, Ratner L, Holland JF. High-dose platinum for the treatment of refractory ovarian cancer. Gynecol Oncol. 1981 Aug; 12(1):64-7.
      View in: PubMed
    354. Weiss RB, Tormey DC, Holland JF, Weinberg VE. Venous thrombosis during multimodal treatment of primary breast carcinoma. Cancer Treat Rep. 1981 Jul-Aug; 65(7-8):677-9.
      View in: PubMed
    355. Plumb M, Holland J. Comparative studies of psychological function in patients with advanced cancer. II. Interviewer-rated current and past psychological symptoms. Psychosom Med. 1981 Jun; 43(3):243-54.
      View in: PubMed
    356. Bruckner HW, Cohen CJ, Goldberg JD, Kabakow B, Wallach RC, Deppe G, Greenspan EM, Gusberg SB, Holland JF. Improved chemotherapy for ovarian cancer with cis-diamminedichloroplatinum and adriamycin. Cancer. 1981 May 1; 47(9):2288-94.
      View in: PubMed
    357. Ambinder EP, Button GR, Cheung T, Goldberg JD, Holland JF. Filtration versus gravity leukapheresis in febrile granulocytopenic patients: a randomized prospective trial. Blood. 1981 May; 57(5):836-41.
      View in: PubMed
    358. Williams CK, Ohnuma T, Holland JF. Inhibition by chemotherapeutic agents of human bone marrow progenitor cells and clonogenic cells of a lymphoblastic cell line. Eur J Cancer. 1981 May; 17(5):519-26.
      View in: PubMed
    359. Chahinian AP, Bhardwaj S, Meyer RJ, Jaffrey IS, Kirschner PA, Holland JF. Treatment of invasive or metastatic thymoma: report of eleven cases. Cancer. 1981 Apr 1; 47(7):1752-61.
      View in: PubMed
    360. Cortes EP, Holland JF, Glidewell O. Osteogenic sarcoma studies by the Cancer and Leukemia Group B. Natl Cancer Inst Monogr. 1981 Apr; (56):207-9.
      View in: PubMed
    361. Bruckner HW, Cohen CJ, Deppe G, Gusberg SB, Holland JF. Effect of cis-diamminedichloroplatinum chemotherapy on the survival of patients with advanced ovarian cancer. Mt Sinai J Med. 1981 Mar-Apr; 48(2):121-3.
      View in: PubMed
    362. Reid LM, Minato N, Gresser I, Holland J, Kadish A, Bloom BR. Influence of anti-mouse interferon serum on the growth and metastasis of tumor cells persistently infected with virus and of human prostatic tumors in athymic nude mice. Proc Natl Acad Sci U S A. 1981 Feb; 78(2):1171-5.
      View in: PubMed
    363. Daniel MD, Tamulevich R, Bekesi JG, King NW, Falk LA, Silva D, Holland JF. Selective antiviral activity of human interferons on primate oncogenic and neurotropic herpesviruses. Int J Cancer. 1981 Jan 15; 27(1):113-21.
      View in: PubMed
    364. Holland JF, Ohnuma T. Asparaginase and amino acids in cancer therapeutics. Cancer and Leukemia Group B Investigators. Cancer Treat Rep. 1981; 65 Suppl 4:123-30.
      View in: PubMed
    365. Williams CK, Svet-Moldavskaya I, Vilcek J, Ohnuma T, Holland JF. Inhibitory effects of human leukocyte and fibroblast interferons on normal and chronic myelogenous leukemic granulocytic progenitor cells. Oncology. 1981; 38(6):356-60.
      View in: PubMed
    366. Hansen HH, Selawry OS, Pajak TF, Spurr CL, Falkson G, Brunner K, Cuttner J, Nissen NI, Holland JF. The superiority of CCNU in the treatment of advanced Hodgkin's disease: Cancer and Leukemia Group B Study. Cancer. 1981 Jan 1; 47(1):14-8.
      View in: PubMed
    367. Roboz J, Jacobs AJ, Holland JF, Deppe G, Cohen CJ. Intraperitoneal infusion of doxorubicin in the treatment of gynecologic carcinomas. Med Pediatr Oncol. 1981; 9(3):245-50.
      View in: PubMed
    368. Gorzynski G, Lebovits A, Holland J, Vugrin D. A comparative study of psychosexual adjustment in men with testicular cancer and acute leukemia. Cancer Detect Prev. 1981; 4(1-4):173-9.
      View in: PubMed
    369. Chahinian AP, Ohnuma T, Greenfield DS, Holland JF. Sequential combination of pyrazofurin and 5-azacytidine in patients with acute myelocytic leukemia and carcinoma. Oncology. 1981; 38(1):7-12.
      View in: PubMed
    370. Cuttner J, Conjalka MS, Reilly M, Goldberg J, Reisman A, Meyer RJ, Holland JF. Association of monocytic leukemia in patients with extreme leukocytosis. Am J Med. 1980 Oct; 69(4):555-8.
      View in: PubMed
    371. Roboz J, Suzuki R, Holland JF. Quantification of arabinitol in serum by selected ion monitoring as a diagnostic technique in invasive candidiasis. J Clin Microbiol. 1980 Oct; 12(4):594-601.
      View in: PubMed
    372. Cooper MR, Pajak TF, Nissen NI, Stutzman L, Brunner K, Cuttner J, Falkson G, Grunwald H, Bank A, Leone L, Seligman BR, Silver RT, Weiss RB, Haurani F, Blom J, Spurr CL, Glidewell OJ, Gottlieb AJ, Holland JF. A new effective four-drug combination of CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) (NSC-79038), vinblastine, prednisone, and procarbazine for the treatment of advanced Hodgkin's disease. Cancer. 1980 Aug 15; 46(4):654-62.
      View in: PubMed
    373. Haid M, Ignatoff J, Khandekar JD, Graham J, Holland J. Urinary bladder metastases from breast carcinoma. Cancer. 1980 Jul 1; 46(1):229-32.
      View in: PubMed
    374. Holland JF, Glidewell O, Cooper RG. Adverse effect of radiotherapy on adjuvant chemotherapy for carcinoma of the breast. Surg Gynecol Obstet. 1980 Jun; 150(6):817-21.
      View in: PubMed
    375. Meyer RJ, Ferreira PP, Cuttner J, Greenberg ML, Goldberg J, Holland JF. Central nervous system involvement at presentation in acute granulocytic leukemia. A prospective cytocentrifuge study. Am J Med. 1980 May; 68(5):691-4.
      View in: PubMed
    376. Takahashi I, Ohnuma T, Kavy S, Bhardwaj S, Holland JF. Interaction of human serum albumin with anticancer agents in vitro. Br J Cancer. 1980 Apr; 41(4):602-8.
      View in: PubMed
    377. Hart RD, Ohnuma T, Holland JF. Initial clinical study with N-(phosphonacetyl)-L-aspartic acid (PALA) in patients with advanced cancer. Cancer Treat Rep. 1980 Apr-May; 64(4-5):617-24.
      View in: PubMed
    378. Rowlands K, Grabau E, Spindler K, Jones C, Semler B, Holland J. Virus protein changes and RNA termini alterations evolving during persistent infection. Cell. 1980 Apr; 19(4):871-80.
      View in: PubMed
    379. Holland J. Interview. Understanding the cancer patient. CA Cancer J Clin. 1980 Mar-Apr; 30(2):103-12.
      View in: PubMed
    380. Richardson CL, Roboz J, Holland JF. Competitive fluorescence polarization study of the binding of 1,4-dihydroxy-5,8-bis[(2-[(2-hydroxyethyl) amino] ethyl]amino] 9-10-anthracenedione to DNA. Res Commun Chem Pathol Pharmacol. 1980 Mar; 27(3):497-506.
      View in: PubMed
    381. Nissen NI, Pajak TF, Leone LA, Bloomfield CD, Kennedy BJ, Ellison RR, Silver RT, Weiss RB, Cuttner J, Falkson G, Kung F, Bergevin PR, Holland JF. Clinical trial of VP 16--213 (NSC 141540) I.V. twice weekly in advanced neoplastic disease: a study by the Cancer and Leukemia Group B. Cancer. 1980 Jan 15; 45(2):232-5.
      View in: PubMed
    382. Ohnuma T, Greenspan EM, Holland JF. Initial clinical study with vindesine: tolerance to weekly iv bolus and 24-hour infusion. Cancer Treat Rep. 1980 Jan; 64(1):25-30.
      View in: PubMed
    383. Ohnuma T, Arkin H, Holland JF. Differences in chemotherapeutic susceptibility of human T-, B-, and non-T-/non-B-lymphocytes in culture. Recent Results Cancer Res. 1980; 75:61-7.
      View in: PubMed
    384. Ohnuma T, Roboz J, Waxman S, Mandel E, Martin DS, Holland JF. Clinical pharmacologic effects of thymidine plus 5-FU. Cancer Treat Rep. 1980; 64(12):1169-77.
      View in: PubMed
    385. Goldsmith MA, Bhardwaj S, Ohnuma T, Greenspan EM, Holland JF. Phase I study of m-AMSA in patients with solid tumors and leukemias. Cancer Clin Trials. 1980; 3(3):197-202.
      View in: PubMed
    386. Coleman M, Silver RT, Pajak TF, Cavalli F, Rai KR, Kostinas JE, Glidewell O, Holland JF. Combination chemotherapy for terminal-phase chronic granulocytic leukemia: cancer and leukemia group B studies. Blood. 1980 Jan; 55(1):29-36.
      View in: PubMed
    387. Chahinian AP, Beranek JT, Suzuki Y, Bekesi JG, Wisniewski L, Selikoff IJ, Holland JF. Transplantation of human malignant mesothelioma into nude mice. Cancer Res. 1980 Jan; 40(1):181-5.
      View in: PubMed
    388. Fernbach B, Takahashi I, Ohnuma T, Holland JF. Clinical and laboratory reevalution of dichloromethotrexate. Recent Results Cancer Res. 1980; 74:56-64.
      View in: PubMed
    389. Tsang PH, Tangnavarad K, Lesnick G, Perloff M, Holland JF, Bekesi JG. Radioisotopic 51Cr-leukocyte adherence inhibition (LAI) assay. I. Demonstration of anti-tumor immunity in patients with breast carcinoma. J Immunol Methods. 1980; 36(2):119-35.
      View in: PubMed
    390. Minato N, Reid L, Neighbour A, Bloom BR, Holland J. Interferon, NK cells and persistent virus infection. Ann N Y Acad Sci. 1980; 350:42-52.
      View in: PubMed
    391. Roboz J, Gleicher N, Wu K, Chanihian P, Kerenyi T, Holland J. Does doxorubicin cross the placenta? Lancet. 1979 Dec 22-29; 2(8156-8157):1382-3.
      View in: PubMed
    392. Svet-Moldavskaya IA, Zinzar SN, Svet-Moldavsky GJ, Mann PE, Bekesi JG, Holland JF, Clarkson BD, Arlin Z, Koziner B. Macrophage-like cell transformation and CFU(c) fluctuations in normal and leukemic human marrow cultures treated by phorbol diester. Biomedicine. 1979 Dec; 31(9-10):252-7.
      View in: PubMed
    393. Roboz J, Suzuki RK, Bekesi JG, Holland JF, Rosenman K, Selikoff IJ. Mass spectrometric identification and quantification of polybrominated biphenyls in blood compartments of exposed Michigan chemical workers. J Environ Pathol Toxicol. 1979 Dec; 3(1-2):363-78.
      View in: PubMed
    394. Chahinian AP, Nogeire C, Ohnuma T, Greenberg ML, Sivak M, Jaffrey IS, Holland JF. Phase I study of weekly maytansine given by iv bolus or 24-hour infusion. Cancer Treat Rep. 1979 Nov-Dec; 63(11-12):1953-60.
      View in: PubMed
    395. Vogl SE, Perloff M, Kaplan BH, Holland JF. Phase I study of iv administration of methanol extraction residue of Bacillus Calmette-Guérin. Cancer Treat Rep. 1979 Nov-Dec; 63(11-12):2039-41.
      View in: PubMed
    396. Derogatis LR, Feldstein M, Morrow G, Schmale A, Schmitt M, Gates C, Murawski B, Holland J, Penman D, Melisaratos N, Enelow AJ, Adler LM. A survey of psychotropic drug prescriptions in an oncology population. Cancer. 1979 Nov; 44(5):1919-29.
      View in: PubMed
    397. Cooper RG, Holland JF, Glidewell O. Adjuvant chemotherapy of breast cancer. Cancer. 1979 Sep; 44(3):793-8.
      View in: PubMed
    398. Cavalli F, Jungi WF, Sonntag RW, Nissen NI, Holland JF. Phase II trial of cis-dichlorodiammineplatinum(II) in advanced malignant lymphoma and small cell lung cancer: preliminary results. Cancer Treat Rep. 1979 Sep-Oct; 63(9-10):1599-603.
      View in: PubMed
    399. Kyle RA, Gailani S, Seligman BR, Blom J, McIntyre OR, Pajak TF, Holland JF. Multiple myeloma resistant to melphalan: treatment with cyclophosphamide, prednisone, and BCNU. Cancer Treat Rep. 1979 Aug; 63(8):1265-9.
      View in: PubMed
    400. Falkson G, Falkson HC, Glidewell O, Weinberg V, Leone L, Holland JF. Improved remission rates and remission duration in young women with metastatic breast cancer following combined oophorectomy and chemotherapy: a study of Cancer and Leukemia Groupe B. Cancer. 1979 Jun; 43(6):2215-22.
      View in: PubMed
    401. Holland JF, Ohnuma T. Lessons from the study of induced alterations in amino acids in patients with cancer. Cancer Treat Rep. 1979 Jun; 63(6):1013-8.
      View in: PubMed
    402. Bekesi JG, Anderson HA, Roboz JP, Roboz J, Fischbein A, Selikoff IJ, Holland JF. Immunologic dysfunction among PBB-exposed Michigan dairy farmers. Ann N Y Acad Sci. 1979 May 31; 320:717-28.
      View in: PubMed
    403. Chahinian AP, Mandel EM, Holland JF, Jaffrey IS, Teirstein AS. MACC (methotrexate, adriamycin, cyclophosphamide and CCNU) in advanced lung cancer. Cancer. 1979 May; 43(5):1590-7.
      View in: PubMed
    404. Minato N, Bloom BR, Jones C, Holland J, Reid LM. Mechanism of rejection of virus persistently infected tumor cells by athymic nude mice. J Exp Med. 1979 May 1; 149(5):1117-33.
      View in: PubMed
    405. Schroeder F, Holland JF, Doi O. Physical properties of murine fibroblasts with altered acyl chain unsaturation. Arch Biochem Biophys. 1979 May; 194(2):431-8.
      View in: PubMed
    406. Ambinder EP, Perloff M, Ohnuma T, Biller HF, Holland JF. High dose methotrexate followed by citrovorum factor reversal in patients with advanced cancer. Cancer. 1979 Apr; 43(4):1177-82.
      View in: PubMed
    407. Takahashi I, Ohnuma T, Holland JF. A comparison of the biological effects of dichloromethotrexate and methotrexate on human leukemic cells in culture. Cancer Res. 1979 Apr; 39(4):1264-8.
      View in: PubMed
    408. Holland JF. Ethics for a clinical investigator. Non primum non nocere. Am J Med. 1979 Apr; 66(4):554-5.
      View in: PubMed
    409. Hoogstraten B, Glidewell O, Holland JF, Blom J, Stutzman L, Nissen NI, Perlberg HJ, Kramer S. Long term follow-up of combination chemotherapy-radiotherapy of stage III Hodgkin's disease: a Cancer and Acute Leukemia Group B study. Cancer. 1979 Apr; 43(4):1234-44.
      View in: PubMed
    410. Goldsmith MA, Suzuki Y, Ohnuma T, Holland JF. Failure of carnitine to prevent adriamycin cardiomyopathy. Cancer Treat Rep. 1979 Apr; 63(4):558-60.
      View in: PubMed
    411. Reid LM, Jones CL, Holland J. Virus carrier state suppresses tumorigenicity of tumor cells in athymic (nude) mice. J Gen Virol. 1979 Mar; 42(3):609-14.
      View in: PubMed
    412. Ohnuma T, Elias F, Holland JF, Henderson E. Pharmacological and therapeutic efficacy of rubidazone in mice. Comparison with daunomycin and adriamycin. Eur J Cancer. 1979 Mar; 15(3):363-71.
      View in: PubMed
    413. Henderson ES, Scharlau C, Cooper MR, Haurani FI, Silver RT, Brunner K, Carey RW, Falkson G, Blom J, Nawabi IV, Levine AS, Bank A, Cuttner J, Cornwell GG, Henry P, Nissen NI, Wiernik PH, Leone L, Wohl H, Rai K, James GW, Weinberg V, Glidewell O, Holland JF. Combination chemotherapy and radiotherapy for acute lymphocytic leukemia in adults: results of CALGB protocol 7113. Leuk Res. 1979; 3(6):395-407.
      View in: PubMed
    414. Wiernik PH, Glidewell OJ, Hoagland HC, Brunner KW, Spurr CL, Cuttner J, Silver RT, Carey RW, DelDuca V, Kung FH, Holland JF. A comparative trial of daunorubicin, cytosine arabinoside, and thioguanine, and a combination of the three agents for the treatment of acute myelocytic leukemia. Med Pediatr Oncol. 1979; 6(3):261-77.
      View in: PubMed
    415. Kedar E, Raanan Z, Kafka I, Holland JF, Bekesi G, Weiss DW. In vitro induction of cytotoxic effector cells against human neoplasms. I. Sensitization conditions and effect of cryopreservation on the induction and expression of cytotoxic responses to allogeneic leukemia cells. J Immunol Methods. 1979; 28(3-4):303-19.
      View in: PubMed
    416. Nissen NI, Pajak TF, Glidewell O, Pedersen-Bjergaard J, Stutzman L, Falkson G, Cuttner J, Blom J, Leone L, Sawitsky A, Coleman M, Haurani F, Spurr CL, Harley JB, Seligman B, Cornell C, Henry P, Senn HJ, Brunner K, Martz G, Maurice P, Bank A, Shapiro L, James GW, Holland JF. A comparative study of a BCNU containing 4-drug program versus MOPP versus 3-drug combinations in advanced Hodgkin's disease: a cooperative study by the Cancer and Leukemia Group B. Cancer. 1979 Jan; 43(1):31-40.
      View in: PubMed
    417. Hayes DM, Pajak TF, Rege V, Falkson G, Spurr CL, Silver RT, Nissen NI, Harley JB, Cuttner J, Glidewell O, Holland JF. Combination chemotherapy for non-Hodgkin lymphomas: a ten year follow-up study. Med Pediatr Oncol. 1979; 6(1):23-38.
      View in: PubMed
    418. Bekesi JG, Roboz J, Anderson HA, Roboz JP, Fischbein AS, Selikoff IJ, Holland JF. Impaired immune function and identification of polybrominated biphenyls (PBB) in blood compartments of exposed Michigan dairy farmers and chemical workers. Drug Chem Toxicol. 1979; 2(1-2):179-91.
      View in: PubMed
    419. Bekesi JG, Holland JF. Impact of specific immunotherapy in acute myelocytic leukemia. Haematol Blood Transfus. 1979; 23:79-87.
      View in: PubMed
    420. Perloff M, Hart RD, Holland JF. Vinblastine, adriamycin, thiotepa, and halotestin (VATH): therapy for advanced breast cancer refractory to prior chemotherapy. Cancer. 1978 Dec; 42(6):2534-7.
      View in: PubMed
    421. Holland JF. Treatment of early breast cancer. Lancet. 1978 Nov 25; 2(8100):1148-9.
      View in: PubMed
    422. Chahinian AP, Suzuki Y, Mandel EM, Holland JF. Diffuse pulmonary malignant mesothelioma: response to doxorubicin and 5-azacytidine. Cancer. 1978 Oct; 42(4):1687-91.
      View in: PubMed
    423. Ohnuma T, Nogeire C, Cuttner J, Holland JF. Phase I study with neocarzinostatin: tolerance to two hour infusion and continuous infusion. Cancer. 1978 Oct; 42(4):1670-9.
      View in: PubMed
    424. Holland JF. Future prospects in lymphoma and leukemia. Cancer. 1978 Aug; 42(2 Suppl):1035-8.
      View in: PubMed
    425. Zinkernagel RM, Althage A, Holland J. Target antigens for H-2-restricted vesicular stomatitis virus-specific cytotoxic T cells. J Immunol. 1978 Aug; 121(2):744-8.
      View in: PubMed
    426. Chahinian AP, Holland JF, Mandel EM. Chemotherapy for malignant mesothelioma with adriamycin and continuous infusion of 5-azacytidine. Cancer Treat Rep. 1978 Jul; 62(7):1108-9.
      View in: PubMed
    427. Bruckner HW, Ratner LH, Cohen CJ, Wallach R, Kabakow B, Greenspan EM, Holland JF. Combination chemotherapy for ovarian carcinoma with cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) after failure of initial chemotherapy. Cancer Treat Rep. 1978 Jul; 62(7):1021-3.
      View in: PubMed
    428. Maurice P, Glidewell O, Jacquillat C, Silver RT, Carey R, Pas AT, Cornell CJ, Burningham RA, Nissen NI, Holland JF. Comparison of methyl-CCNU and CCNU in patients with advanced forms of Hodgkin's disease, lymphosarcoma nad reticulum cell sarcoma. Cancer. 1978 May; 41(5):1658-63.
      View in: PubMed
    429. Bruckner HW, Cohen CJ, Wallach RC, Kabakow B, Deppe G, Greenspan EM, Gusberg SB, Holland JF. Treatment of advanced ovarian cancer with cis=dichlorodiammineplatinum(II): poor-risk patients with intensive prior therapy. Cancer Treat Rep. 1978 Apr; 62(4):555-8.
      View in: PubMed
    430. Ohnuma T, Arkin H, Minowada J, Holland JF. Differential chemotherapeutic susceptibility of human T-lymphocytes and B-lymphocytes in culture. J Natl Cancer Inst. 1978 Apr; 60(4):749-52.
      View in: PubMed
    431. Bekesi JG, Holland JF, Anderson HA, Fischbein AS, Rom W, Wolff MS, Selikoff IJ. Lymphocyte function of Michigan dairy farmers exposed to polybrominated biphenyls. Science. 1978 Mar 17; 199(4334):1207-9.
      View in: PubMed
    432. Holland JF. Therapeutic considerations in acute lymphocytic leukemia. Am J Pathol. 1978 Feb; 90(2):521-8.
      View in: PubMed
    433. Kung FH, Nythan WL, Cuttner J, Falkson G, Lanzkowsky P, Del Duca V, Nawabi IU, Koch K, Pluess H, Freeman A, Burgert EO, Leone LA, Ruymann F, Patterson RB, Degnan T, Hakami N, Pajak TF, Holland J. Vincristine, prednisone and L-asparaginase in the induction of remission in children with acute lymphoblastic leukemia following relapse. Cancer. 1978 Feb; 41(2):428-34.
      View in: PubMed
    434. Cortes EP, Holland JF, Glidewell O. Amputation and adriamycin in primary osteosarcoma: a 5-year report. Cancer Treat Rep. 1978 Feb; 62(2):271-7.
      View in: PubMed
    435. Silver RT, Sawitsky A, Rai K, Holland JF, Glidewell O. Guidelines for protocol studies in chronic lymphocytic leukemia. Am J Hematol. 1978; 4(4):343-58.
      View in: PubMed
    436. Patel IP, Ambinder E, Holland JF, Aledort LM. In vitro and in vivo comparison of single-donor platelets and multiple-donor pooled platelets transfusions in leukemic patients. Transfusion. 1978 Jan-Feb; 18(1):116-9.
      View in: PubMed
    437. Gattanell PN, Perloff M, Holland JF. Hepatocellular carcinoma in a young woman with prolonged exposure to oral contraceptives. Med Pediatr Oncol. 1978; 4(2):99-103.
      View in: PubMed
    438. Holland JF. Clinical aspects of drug resistance. Antibiot Chemother (1971). 1978; 23:238-46.
      View in: PubMed
    439. Cortes EP, Holland JF, Glidewell O. Adjuvant therapy of operable primary osteosarcoma-cancer and Leukemia Group B experience. Recent Results Cancer Res. 1978; 68:16-24.
      View in: PubMed
    440. Meyer RJ, Cuttner J, Truog P, Ambinder EP, Holland JF. Therapeutic leukopheresis of acute myelo-monocytic leukemia in pregnancy. Med Pediatr Oncol. 1978; 4(1):77-83.
      View in: PubMed
    441. Holland JF, Cortes EP. Surgical adjuvant chemotherapy in sarcomas. Antibiot Chemother (1971). 1978; 24:95-9.
      View in: PubMed
    442. Forcier RJ, McIntyre OR, Nissen NI, Pajak TF, Glidewell O, Holland JF. Combination chemotherapy of non-Hodgkin lymphoma. Med Pediatr Oncol. 1978; 4(4):351-62.
      View in: PubMed
    443. Chahinian AP, Holland JF. Treatment of diffuse malignant mesothelioma: a review. Mt Sinai J Med. 1978 Jan-Feb; 45(1):54-67.
      View in: PubMed
    444. Silver RT, Young RC, Holland JF. Some new aspects of modern cancer chemotherapy. Am J Med. 1977 Nov; 63(5):772-87.
      View in: PubMed
    445. Chahinian AP, Holland JF, Teirstein AS, Kirschner PA. Combination chemotherapy (MACC) in bronchogenic carcinoma. Mt Sinai J Med. 1977 Nov-Dec; 44(6):844-5.
      View in: PubMed
    446. Ohnuma T, Holland JF, Arkin H, Minowada J. L-asparagine requirements of human T-lymphocytes and B-lymphocytes in culture. J Natl Cancer Inst. 1977 Oct; 59(4):1061-3.
      View in: PubMed
    447. Holland JF. The cancer breakthrough myth. Mt Sinai J Med. 1977 Sep-Oct; 44(5):674-81.
      View in: PubMed
    448. Bekesi JG, Holland JF, Roboz JP. Specific immunotherapy with neuraminidase-modified leukemic cells: experimental and clinical trials. Med Clin North Am. 1977 Sep; 61(5):1083-100.
      View in: PubMed
    449. Nissen NI, Pajak T, Glidewell O, Blom H, Flaherty M, Hayes D, McIntyre R, Holland JF. Overview of four clinical studies of chemotherapy for stage III and IV non-Hodgkin's lymphomas by the Cancer and Leukemia Group B. Cancer Treat Rep. 1977 Sep; 61(6):1097-107.
      View in: PubMed
    450. Holland JF. Therapy of primary breast cancer. Isr J Med Sci. 1977 Aug; 13(8):829-36.
      View in: PubMed
    451. Holland J, Plumb M, Yates J, Harris S, Tuttolomondo A, Holmes J, Holland JF. Psychological response of patients with acute leukemia to germ-free environments. Cancer. 1977 Aug; 40(2):871-9.
      View in: PubMed
    452. Vogl SE, Lumb G, Bekesi JG, Holland JF. Preclinical study of iv administration of the methanol extraction residue of bacillus Calmette-Guérin. Cancer Treat Rep. 1977 Aug; 61(5):901-3.
      View in: PubMed
    453. Selawry O, Krant M, Scotto J, Kazam E, Schneiderman M, Olson K, Shnider B, Edmonson J, Holland J, Taylor S. Methotrexate compared with placebo in lung cancer. Cancer. 1977 Jul; 40(1):4-8.
      View in: PubMed
    454. Holland JF, Bekesi JG, Cuttner J, Glidewell O. Chemoimmunotherapy in acute myelocytic leukemia. Isr J Med Sci. 1977 Jul; 13(7):694-700.
      View in: PubMed
    455. Ohnuma T, Roboz J, Shapiro ML, Holland JF. Pharmacological and biochemical effects of pyrazofurin in humans. Cancer Res. 1977 Jul; 37(7 Pt 1):2043-9.
      View in: PubMed
    456. Ohnuma T, Holland JF. Nutritional consequences of cancer chemotherapy and immunotherapy. Cancer Res. 1977 Jul; 37(7 Pt 2):2395-406.
      View in: PubMed
    457. Plumb MM, Holland J. Comparative studies of psychological function in patients with advanced cancer--I. Self-reported depressive symptoms. Psychosom Med. 1977 Jul-Aug; 39(4):264-76.
      View in: PubMed
    458. Chahinian PA, Arnold DJ, Cohen JM, Purpora DP, Jaffrey IS, Teirstein AS, Kirschner PA, Holland JF. Chemotherapy for bronchogenic carcinoma. Methotrexate, doxorubicin, cyclophosphamide, and lomustine. JAMA. 1977 May 30; 237(22):2392-6.
      View in: PubMed
    459. Ohnuma T, Holland JF. Initial clinical study with pyrazofurin. Cancer Treat Rep. 1977 May-Jun; 61(3):389-94.
      View in: PubMed
    460. Perloff M, Holland JF, Lumb GJ, Bekesi JG. Effects of methanol extraction residue of Bacillus calmette-Guérin in humans. Cancer Res. 1977 Apr; 37(4):1191-6.
      View in: PubMed
    461. Perloff M, Holland JF. Surgical adjuvant chemotherapy. Annu Rev Med. 1977; 28:475-88.
      View in: PubMed
    462. Bekesi JG, Holland JF. Active immunotherapy in leukemia with neuraminidase-modified leukemic cells. Recent Results Cancer Res. 1977; (62):78-89.
      View in: PubMed
    463. Jones B, Holland JF, Glidewell O, Jacquillat C, Weil M, Pochedly C, Sinks L, Chevalier L, Maurer HM, Koch K, Falkson G, Patterson R, Seligman B, Sartorius J, Kung F, Haurani F, Stuart M, Burgert EO, Ruymann F, Sawitsky A, Forman E, Pluess H, Truman J, Hakami N. Optimal use of L-asparaginase (NSC-109229) in acute lymphocytic leukemia. Med Pediatr Oncol. 1977; 3(4):387-400.
      View in: PubMed
    464. Jacquillat C, Weil M, Auclerc MF, Schaison G, Holland JF. [Treatment of acute leukemia]. Nouv Rev Fr Hematol Blood Cells. 1977; 18(2):293-313.
      View in: PubMed
    465. Lovinger R, Holland J, Kaplan S, Grumbach M, Boryczka AT, Shackelford R, Salmon J, Reid IA, Ganong WF. Pharmacological evidence for stimulation of growth hormone secretion by a central noradrenergic system in dogs. Neuroscience. 1976 Dec; 1(6):443-50.
      View in: PubMed
    466. Jeney A, Fox BW, Garrett JV, Fox M, Holland J. The effect of dibromodulcitol on resting and dividing lymphoid cells. Chem Biol Interact. 1976 Dec; 15(4):299-307.
      View in: PubMed
    467. Holland JF, Glidewell O, Ellison RR, Corey RW, Schwartz J, Wallace HJ, Hoagland HC, Wiernik P, Rai K, Bekesi JG, Cuttner J. Acute myelocytic leukemia. Arch Intern Med. 1976 Dec; 136(12):1377-81.
      View in: PubMed
    468. Schroeder F, Holland JF, Vagelos PR. Use of beta-parinaric acid, a novel fouorimetric probe, to determine characteristic temperatures of membranes and membrane lipids from cultured animal cells. J Biol Chem. 1976 Nov 10; 251(21):6739-46.
      View in: PubMed
    469. Schroeder F, Holland JF, Vagelos PR. Physical properties of membranes isolated from tissue culture cells with altered phospholipid composition. J Biol Chem. 1976 Nov 10; 251(21):6747-56.
      View in: PubMed
    470. Leiber L, Plumb MM, Gerstenzang ML, Holland J. The communication of affection between cancer patients and their spouses. Psychosom Med. 1976 Nov-Dec; 38(6):379-89.
      View in: PubMed
    471. Martin F, Maine J, Sweeley CC, Holland JF. The free-falling drop detector--a nover fluorescence detector for high-performance liquid chromatography. Clin Chem. 1976 Sep; 22(9):1434-7.
      View in: PubMed
    472. Reddi KK, Holland JF. Elevated serum ribonuclease in patients with pancreatic cancer. Proc Natl Acad Sci U S A. 1976 Jul; 73(7):2308-10.
      View in: PubMed
    473. Vogl S, Ohnums T, Perloff M, Holland JF. Combination chemotherapy with adriamycin and cis-diamminedichloroplatinum in patients with neoplastic diseases. Cancer. 1976 Jul; 38(1):21-6.
      View in: PubMed
    474. Holland JF. Breast cancer and chemotherapy. Science. 1976 Jun 11; 192(4244):1062-3.
      View in: PubMed
    475. Holland JF, Bekesi JG. Immunotherapy of human leukemia with neuraminidase-modified cells. Med Clin North Am. 1976 May; 60(3):539-49.
      View in: PubMed
    476. Bekesi JG, Roboz JP, Holland JF. Characteristics of immunity induced by neuraminidase-treated lymphosarcoma cells in C3H (MTV+) and C3H (MTV-) mice. Isr J Med Sci. 1976 Apr-May; 12(4-5):288-303.
      View in: PubMed
    477. Holland JF. Editorial: Major advance in breast-cancer therapy. N Engl J Med. 1976 Feb 19; 294(8):440-1.
      View in: PubMed
    478. Holland JF. Immunological control of human leukemia: discussion. Cancer Res. 1976 Feb; 36(2 pt 2):657-9.
      View in: PubMed
    479. Bekesi JG, Roboz JP, Zimmerman E, Holland JF. Treatment of spontaneous leukemia in AKR mice with chemotherapy, immunotherapy, or interferon. Cancer Res. 1976 Feb; 36(2 pt 2):631-9.
      View in: PubMed
    480. Bekesi JG, Roboz JP, Holland JF. Therapeutic effectiveness of neuraminidase-treated tumor cells as an immunogen in man and experimental animals with leukemia. Ann N Y Acad Sci. 1976; 277(00):313-31.
      View in: PubMed
    481. Horváth M, Holland J. Proceedings: Effect of 60Co-gamma-irradiation on the mixed disulphides of radioprotector MEG in splitting with enzymes of rat liver cytoplasm. Br J Cancer. 1975 Dec; 32(6):755.
      View in: PubMed
    482. Glidewell O, Holland JF. Comparative prognosis of the acute leukemias. Bibl Haematol. 1975 Oct; (43):527-30.
      View in: PubMed
    483. Holland JF. Therapy of acute leukemia. Bibl Haematol. 1975 Oct; (43):491-4.
      View in: PubMed
    484. Bekesi JG, Roboz JP, Holland JF. Chemoimmunotherapy in human and experimental leukemia. Bibl Haematol. 1975 Oct; (43):524-5.
      View in: PubMed
    485. Hossfeld DK, Holland JF, Cooper RG, Ellison RR. Chromosome studies in acute leukemias developing in patients with multiple myeloma. Cancer Res. 1975 Oct; 35(10):2808-13.
      View in: PubMed
    486. Ohnuma T, Holland JF, Chen JH. Pharmacological and therapeutic efficacy of daunomycin:DNA complex in mice. Cancer Res. 1975 Jul; 35(7):1767-72.
      View in: PubMed
    487. Holland J. [Psychological aspects of cancer]. Klin Med (Mosk). 1975 Jun; 53(6):140-4.
      View in: PubMed
    488. Kyle RA, Seligman BR, Wallace HJ, Silver RT, Glidewell O, Holland JF. Mutiple myeloma resistant to melphalan (NSC-8806) treated with cyclophosphamide (NSC-26271), prednisone (NSC-10023), and chloroquine (NSC-187208). Cancer Chemother Rep. 1975 May-Jun; 59(3):557-62.
      View in: PubMed
    489. Higby DJ, Yates JW, Henderson ES, Holland JF. Filtration leukapheresis for granulocyte transfusion therapy. Clinical and laboratory studies. N Engl J Med. 1975 Apr 10; 292(15):761-6.
      View in: PubMed
    490. Moon JH, Gailani S, Cooper MR, Hayes DM, Rege VB, Blom J, Falkson G, Maurice P, Brunner K, Glidewell O, Holland JF. Comparison of the combination of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and vincristine with two dose schedules of 5-(3,3-dimethyl-1-triazino) imidazole 4-carboxamide (DTIC) in the treatment of disseminated malignant melanoma. Cancer. 1975 Feb; 35(2):368-71.
      View in: PubMed
    491. Dave C, Higby D, Mattern J, Holland JF, Grace JT. Pharmacokinetics of guanazole in patients with acute myelocytic leukemia. Clin Pharmacol Ther. 1975 Jan; 17(1):36-43.
      View in: PubMed
    492. Cuttner J, Wasserman LR, Martz G, Sonntag RW, Kyle RA, Silver RT, Spurr C, Harley JB, Wiernik PM, Cornwell GG, Falkson G, Glidewell O, Holland JF. The use of low-dose prednisone and melphalan in the treatment of poor-risk patients with multiple myeloma. Med Pediatr Oncol. 1975; 1(3):207-16.
      View in: PubMed
    493. Cortes EP, Holland JF, Wang JJ, Sinks LF, Blom J, Senn H, Bank A, Glidewell O. Amputation and adriamycin in primary osteosarcoma. N Engl J Med. 1974 Nov 7; 291(19):998-1000.
      View in: PubMed
    494. Sweeley CC, Young ND, Holland JF, Gates SC. Rapid computerized identification of compounds in complex biological mixtures by gas chromatography-mass spectrometry. J Chromatogr. 1974 Nov 6; 99(0):507-17.
      View in: PubMed
    495. Jones B, Kung F, Chevalier L, Forman EN, Rausen A, Koch K, Desposito F, Maurer H, Jacquillat C, Degnan TJ, Pluess H, Desforges J, Patterson RB, Glidewell O, Holland JF. Chemotherapy of reticuloendotheliosis. Comparison of methotrexate plus prednisone vs. vincristine plus prednisone. Cancer. 1974 Oct; 34(4):1011-7.
      View in: PubMed
    496. Björnsson S, Yates JW, Mittelman A, Holland JF. Major surgery in acute leukemia. Cancer. 1974 Oct; 34(4):1272-5.
      View in: PubMed
    497. Cortes EP, Takita H, Holland JF. Adriamycin in advanced bronchogenic carcinoma. Cancer. 1974 Sep; 34(3):518-25.
      View in: PubMed
    498. Higby DJ, Cohen E, Holland JF, Sinks L. The prophylactic treatment of thrombocytopenic leukemic patients with platelets: a double blind study. Transfusion. 1974 Sep-Oct; 14(5):440-6.
      View in: PubMed
    499. Higby DJ, Wallace HJ, Albert D, Holland JF. Diamminodichloroplatinum in the chemotherapy of testicular tumors. J Urol. 1974 Jul; 112(1):100-4.
      View in: PubMed
    500. Mishler JM, Higby DJ, Rhomberg W, Cohen E, Nicora RW, Holland JF. Hydroxyethyl starch and dexamethasone as an adjunct to leukocyte separation with the IBM blood cell separator. Transfusion. 1974 Jul-Aug; 14(4):352-6.
      View in: PubMed
    501. Holland J, Fasanello S, Onuma T. Psychiatric symptoms associated with L-asparaginase administration. J Psychiatr Res. 1974 May; 10(2):105-13.
      View in: PubMed
    502. Onuma T, Holland JF, Masuda H, Waligunda JA, Goldberg GA. Microbiological assay of bleomycin: inactivation, tissue distribution, and clearance. Cancer. 1974 May; 33(5):1230-8.
      View in: PubMed
    503. Higby DJ, Wallace HJ, Albert DJ, Holland JF. Diaminodichloroplatinum: a phase I study showing responses in testicular and other tumors. Cancer. 1974 May; 33(5):1219-5.
      View in: PubMed
    504. Yates JW, Holland JF. A controlled study of isolation and endogenous microbial suppression in acute myelocytic leukemia patients. Cancer. 1973 Dec; 32(6):1490-8.
      View in: PubMed
    505. Yates JW, Wallace HJ, Ellison RR, Holland JF. Cytosine arabinoside (NSC-63878) and daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia. Cancer Chemother Rep. 1973 Nov-Dec; 57(4):485-8.
      View in: PubMed
    506. Higby DJ, Wallace HJ, Holland JF. Cis-diamminedichloroplatinum (NSC-119875): a phase I study. Cancer Chemother Rep. 1973 Nov-Dec; 57(4):459-63.
      View in: PubMed
    507. Rosenfeld MG, Abrass IB, Mendelsohn J, Miller HI, Holland J. Poly(A): possible role in translation of poly(A)-rich RNA. Proc Soc Exp Biol Med. 1973 Oct 1; 144(1):215-9.
      View in: PubMed
    508. Band PR, Holland JF, Bernard J, Weil M, Walker M, Rall D. Treatment of central nervous system leukemia with intrathecal cytosine arabinoside. Cancer. 1973 Oct; 32(4):744-8.
      View in: PubMed
    509. Barlow JJ, Piver MS, Chuang JT, Cortes EP, Onuma T, Holland JF. Adriamycin and bleomycin, alone and in combination, in gynecologic cancers. Cancer. 1973 Oct; 32(4):735-43.
      View in: PubMed
    510. Baxt W, Yates JW, Wallace HJ, Holland JF, Spiegelman S. Leukemia-specific DNA sequences in leukocytes of the leukemic member of identical twins. Proc Natl Acad Sci U S A. 1973 Sep; 70(9):2629-32.
      View in: PubMed
    511. Holland JF, Scharlau C, Gailani S, Krant MJ, Olson KB, Horton J, Shnider BI, Lynch JJ, Owens A, Carbone PP, Colsky J, Grob D, Miller SP, Hall TC. Vincristine treatment of advanced cancer: a cooperative study of 392 cases. Cancer Res. 1973 Jun; 33(6):1258-64.
      View in: PubMed
    512. Kyle RA, Costa G, Cooper MR, Ogawa M, Silver RT, Glidewell O, Holland JF. Evaluation of aniline mustard in patients with multiple myeloma. Cancer Res. 1973 May; 33(5):956-60.
      View in: PubMed
    513. Weil M, Glidewell OJ, Jacquillat C, Levy R, Serpick AA, Wiernik PH, Cuttner J, Hoogstraten B, Wasserman L, Ellison RR, Gailani S, Brunner K, Silver RT, Rege VB, Cooper MR, Lowenstein L, Nissen NI, Haurani F, Blom J, Boiron M, Bernard J, Holland JF. Daunorubicin in the therapy of acute granulocytic leukemia. Cancer Res. 1973 May; 33(5):921-8.
      View in: PubMed
    514. Yakar D, Holland JF, Ellison RR, Freeman A. Clinical pharmacological trial of guanazole. Cancer Res. 1973 May; 33(5):972-5.
      View in: PubMed
    515. Hoogstraten B, Holland JF, Kramer S, Glidewell OJ. Combination chemotherapy-radiotherapy for stage 3 Hodgkin's disease. An acute leukemia group B study. Arch Intern Med. 1973 Mar; 131(3):424-8.
      View in: PubMed
    516. Nissen NI, Stutzman L, Holland JF, Glidewell OJ. Chemotherapy of Hodgkin's disease in studies by acute leukemia group B. Arch Intern Med. 1973 Mar; 131(3):396-401.
      View in: PubMed
    517. Holland JF, Sweeley CC, Thrush RE, Teets RE, Bieber MA. On-line computer controlled multiple ion detection in combined gas chromatography-mass spectrometry. Anal Chem. 1973 Feb; 45(2):308-14.
      View in: PubMed
    518. Band PR, Ross CA, Holland JF. Comparison of two dose schedules of dichloromethotrexate (NSC-29630) in lung cancer. Cancer Chemother Rep. 1973 Feb; 57(1):79-82.
      View in: PubMed
    519. Holland J, Sgroi SM, Marwit SJ, Solkoff N. The ICU syndrome: fact or fancy. Int J Psychiatry Med. 1973; 4(3):241-9.
      View in: PubMed
    520. Kennedy BJ, Calabresi P, Carbone PP, Frei E, Holland JF, Owens AH, Sleisenger MH, Beck JC. Training program in medical oncology. Ann Intern Med. 1973 Jan; 78(1):127-30.
      View in: PubMed
    521. Glidewell OJ, Holland JF. Clinical trials of the acute leukemia group B in acute lymphocytic leukemia of childhood. Bibl Haematol. 1973; 39:1053-67.
      View in: PubMed
    522. Holland JF, Glidewell O. Chemotherapy of acute lymphocytic leukemia of childhood. Cancer. 1972 Dec; 30(6):1480-7.
      View in: PubMed
    523. Jones B, Cuttner J, Levy RN, Patterson RB, Kung F, Pleuss HJ, Falkson G, Treat CL, Haurani F, Burgert EO, Rosner F, Carey RW, Lukens J, Blom J, Degnan TJ, Wohl H, Glidewell O, Holland JF. Daunorubicin (NSC-83142) versus daunorubicin plus prednisone (NSC-10023) versus daunorubicin plus vincristine (NSC-67574) plus prednisone in advanced childhood acute lymphocytic leukemia. Cancer Chemother Rep. 1972 Dec; 56(6):729-37.
      View in: PubMed
    524. Holland JF. Combination therapy of acute lymphocytic leukemia of children. JAMA. 1972 Nov 27; 222(9):1169-70.
      View in: PubMed
    525. Holland JF, Glidewell O. Oncologists' reply: survival expectancy in acute lymphocytic leukemia. N Engl J Med. 1972 Oct 12; 287(15):769-77.
      View in: PubMed
    526. Palma J, Gailani S, Freeman A, Sinks L, Holland JF. Treatment of metastatic Ewing's sarcoma with BCNU. Cancer. 1972 Oct; 30(4):909-13.
      View in: PubMed
    527. Onuma T, Selawry OS, Holland JF, DeVita VT, Shedd DP, Hansen HH, Muggia FM. Clinical study with bleomycin: tolerance to twice weekly dosage. Cancer. 1972 Oct; 30(4):914-22.
      View in: PubMed
    528. Onuma T, Holland JF, Sako K, Shedd DP. Effects of combination therapy with bleomycin (NSC-125066) and dibromodulcitol (NSC-104800) on squamous cell carcinoma in man. Cancer Chemother Rep. 1972 Oct; 56(5):625-33.
      View in: PubMed
    529. Perrault J, Holland J. Variability of vesicular stomatitis virus autointerference with different host cells and virus serotypes. Virology. 1972 Oct; 50(1):148-58.
      View in: PubMed
    530. Cores EP, Holland JF, Wang JJ, Sinks LF. Doxorubicin in disseminated osteosarcoma. JAMA. 1972 Sep 4; 221(10):1132-8.
      View in: PubMed
    531. Ellison RR, Hoogstraten B, Holland JF, Levy RN, Lee SL, Silver RT, Leone LA, Cooper T, Oberfield RA, Ten Pas A, Blom J, Jacquillat C, Haurani F. Intermittent therapy with 6-mercaptopurine (NSC-755) and methotrexate (NSC-740) given intravenously to adults with acute leukemia. Cancer Chemother Rep. 1972 Aug; 56(4):535-42.
      View in: PubMed
    532. Ohnuma T, Holland JF, Meyer P. Erwinia carotovora asparaginase in patients with prior anaphylaxis to asparaginase from E. coli. Cancer. 1972 Aug; 30(2):376-81.
      View in: PubMed
    533. Bekesi JG, St Arneault G, Walter L, Holland JF. Immunogenicity of leukemia L1210 cells after neuraminidase treatment. J Natl Cancer Inst. 1972 Jul; 49(1):107-18.
      View in: PubMed
    534. Gailani S, Holland JF, Falkson G, Leone L, Burningham R, Larsen V. Comparison of treatment of metastatic gastrointestinal cancer with 5-fluorouracil (5-FU) to a combination of 5-FU with cytosine arabinoside. Cancer. 1972 May; 29(5):1308-13.
      View in: PubMed
    535. Banerjee TK, Senn H, Holland JF. Comparative studies on localized leukocyte mobilization in patients with chronic myelocytic leukemia. Cancer. 1972 Mar; 29(3):637-44.
      View in: PubMed
    536. Peters WP, Holland JF, Senn H, Rhomberg W, Banerjee T. Corticosteroid administration and localized leukocyte mobilization in man. N Engl J Med. 1972 Feb 17; 286(7):342-5.
      View in: PubMed
    537. Cortes EP, Holland JF, Moskowitz R, Depoli E. Effects of mithramycin on bone resorption in vitro. Cancer Res. 1972 Jan; 32(1):74-6.
      View in: PubMed
    538. Gailani S, Holland JF, Glick A. Effects of boxidine on human serum sterols and neoplasms. Clin Pharmacol Ther. 1972 Jan-Feb; 13(1):91-6.
      View in: PubMed
    539. Bekesi JG, St-Arneault G, Holland JF. Increase of leukemia L1210 immunogenicity by Vibrio cholerae neuraminidase treatment. Cancer Res. 1971 Dec; 31(12):2130-2.
      View in: PubMed
    540. Goldin A, Sandberg JS, Henderson ES, Newman JW, Frei E, Holland JF. The chemotherapy of human and animal acute leukemia. Cancer Chemother Rep. 1971 Nov; 55(4):309-505.
      View in: PubMed
    541. Onuma T, Waligunda J, Holland JF. Amino acid requirements in vitro of human leukemic cells. Cancer Res. 1971 Nov; 31(11):1640-4.
      View in: PubMed
    542. Wang JJ, Cortes E, Sinks LF, Holland JF. Therapeutic effect and toxicity of adriamycin in patients with neoplastic disease. Cancer. 1971 Oct; 28(4):837-43.
      View in: PubMed
    543. Holland JF. E Pluribus Unum: Presidential address. Cancer Res. 1971 Oct; 31(10):1319-29.
      View in: PubMed
    544. Onuma T, Rosner F, Levy RN, Cuttner J, Moon JH, Silver RT, Blom J, Falkson G, Burningham R, Glidewell O, Holland JF. Treatment of adult leukemia with L-asparaginase (NSC-109229). Cancer Chemother Rep. 1971 Jun; 55(3):269-75.
      View in: PubMed
    545. Hansen HH, Selawry OS, Holland JF, McCall CB. The variability of individual tolerance to methotrexate in cancer patients. Br J Cancer. 1971 Jun; 25(2):298-305.
      View in: PubMed
    546. Holland JF, Senn H, Banerjee T. Quantitative studies of localized leukocyte mobilization in acute leukemia. Blood. 1971 May; 37(5):499-511.
      View in: PubMed
    547. Rosner F, Glidewell O, Ellison RR, Lee SL, Cuttner J, Gailani S, Morrison AN, Hoogstraten B, Weil M, Leone L, Levy RN, Cooper T, Brunner KW, Serpick A, Burmingham RA, Holland JF. Failure of hydroxyurea (NSC-32065) and prednisone (NSC-10023) in the treatment of acute myelocytic leukemia. Cancer Chemother Rep. 1971 Apr; 55(2):199-204.
      View in: PubMed
    548. Jones B, Holland JF, Morrison AR, Lee SL, Sinks LF, Cuttner J, Rausen A, Kung F, Pluss HJ, Haurani FI, Patterson RB, Blom J, Burgert EO, Moon JH, Chevalier L, Sawitsky A, Albala MM, Forcier RJ, Falkson G, Glidewell O. Daunorubicin (NSC 82151) in the treatment of advanced childhood lymphoblastic leukemia. Cancer Res. 1971 Feb; 31(2):84-90.
      View in: PubMed
    549. Koza I, Holland JF, Cohen E. Histocompatible leukocyte transfusion during granulocytopenia. Neoplasma. 1971; 18(2):185-91.
      View in: PubMed
    550. Holland JF. Epidemic acute leukemia. N Engl J Med. 1970 Nov 19; 283(21):1165-6.
      View in: PubMed
    551. Ohnuma T, Holland JF, Freeman A, Sinks LF. Biochemical and pharmacological studies with asparaginase in man. Cancer Res. 1970 Sep; 30(9):2297-305.
      View in: PubMed
    552. Nagel GA, St Arneault G, Holland JF, Kirkpatrick D, Kirkpatrick R. Cell-mediated immunity against malignant melanoma in monozygous twins. Cancer Res. 1970 Jun; 30(6):1828-32.
      View in: PubMed
    553. St-Arneault G, Nagel G, Kirkpatrick D, Kirkpatrick R, Holland JF. Melanoma in twins. Cutaneous malignant melanoma in identical twins from a set of triplets. Cancer. 1970 Mar; 25(3):672-7.
      View in: PubMed
    554. Levine PH, Regelson W, Holland JF. Chloramphenicol-associated encephalopathy. Clin Pharmacol Ther. 1970 Mar-Apr; 11(2):194-9.
      View in: PubMed
    555. Senn HJ, Holland JF. [Functional evaluation of the defense against infection in leukemias]. Schweiz Med Wochenschr. 1970 Feb 14; 100(7):308-10.
      View in: PubMed
    556. Holland JF. Hopes for tomorrow versus realities of today: therapy and prognosis in acute lymphocytic leukemia of childhood. Pediatrics. 1970 Feb; 45(2):191-3.
      View in: PubMed
    557. Gailani SD, Carey RW, Holland JF, O'Malley JA. Studies of folate deficiency in patients with neoplastic diseases. Cancer Res. 1970 Feb; 30(2):327-33.
      View in: PubMed
    558. Holland JF. Therapy of acute leukemia. Hamatol Bluttransfus. 1970; 9:58-65.
      View in: PubMed
    559. Holland JF. Systemic chemotherapy 1968. Proc Natl Cancer Conf. 1970; 6:609-15.
      View in: PubMed
    560. Nagel GA, Holland JF. The mixed lymphocyte tumor cell culture and the fluorescein diacetate cytotoxicity test. Two useful methods for the demonstration of cell mediated tumor specific immunity in man. Acta Haematol. 1970; 44(3):129-41.
      View in: PubMed
    561. Nagel GA, Matulewski TJ, Holland JF. Factors affecting the mixed leucocyte culture as histocompatibility test. II. Comparative studies with granulocytes, lymphocytes and macrophages. Eur Surg Res. 1970; 2(5):370-9.
      View in: PubMed
    562. Senn HJ, Chu B, O'Malley J, Holland JF. Experiemental and clinical studies on muramidase (lysozyme). I. Muramidase activity of normal human blood cells and inflammatory exudates. Acta Haematol. 1970; 44(2):65-77.
      View in: PubMed
    563. Holland J, Antoni F. Effect of heavy water on the amino acid incorporation of subcellular liver particles. Acta Biochim Biophys Acad Sci Hung. 1970; 5(2):249-57.
      View in: PubMed
    564. Holland JF. Prediction of time death in patients with advanced cancer. Ann N Y Acad Sci. 1969 Dec 19; 164(3):678-86.
      View in: PubMed
    565. Ohnuma T, Holland JF, Yates J, Grew S. B.C.G. vaccination and asparaginase. Lancet. 1969 Dec 13; 2(7633):1310.
      View in: PubMed
    566. Ohnuma T, Holland JF, Nagel G, Arneault GS. Effects of L-asparaginase in acute myelocytic leukemia. JAMA. 1969 Dec 8; 210(10):1919-21.
      View in: PubMed
    567. Holland JF. Formal discussion of J. H. Burchenal's paper, "Success and failure in present chemotherapy and the implications of asparaginase". Cancer Res. 1969 Dec; 29(12):2270-1.
      View in: PubMed
    568. Senn H, Holland JF, Banerjee T. Kinetic and comparative studies on localized leukocyte mobilization in normal man. J Lab Clin Med. 1969 Nov; 74(5):742-56.
      View in: PubMed
    569. Holland JF. Who should treat acute leukemia? JAMA. 1969 Sep 8; 209(10):1511-3.
      View in: PubMed
    570. Holland JF. Introduction--leukemia and lymphoma. I. Semin Hematol. 1969 Jul; 6(3):226-7.
      View in: PubMed
    571. Holland JF. Cyclophosphamide for acute leukemia. N Engl J Med. 1969 Apr 17; 280(16):903.
      View in: PubMed
    572. Senn H, Holland JF. Plastic skin chamber technique for comparative studies on localized leukocyte mobilization in man. Rev Fr Etud Clin Biol. 1969 Apr; 14(4):373-7.
      View in: PubMed
    573. Holland JF. Chemotherapeutic goals in acute leukemia. N Engl J Med. 1969 Jan 23; 280(4):216-7.
      View in: PubMed
    574. Ellison RR, Holland JF, Weil M, Jacquillat C, Boiron M, Bernard J, Sawitsky A, Rosner F, Gussoff B, Silver RT, Karanas A, Cuttner J, Spurr CL, Hayes DM, Blom J, Leone LA, Haurani F, Kyle R, Hutchison JL, Forcier RJ, Moon JH. Arabinosyl cytosine: a useful agent in the treatment of acute leukemia in adults. Blood. 1968 Oct; 32(4):507-23.
      View in: PubMed
    575. Selawry OS, Holland JF, Wolman IJ. Effect of vincristine (NSC-67574) on malignant solid tumors in children. Cancer Chemother Rep. 1968 Jun; 52(4):497-500.
      View in: PubMed
    576. Gailani SD, Holland JF, Nussbaum A, Olson KB. Clinical and biochemical studies of pyridoxine deficiency in patients with neoplastic diseases. Cancer. 1968 May; 21(5):975-88.
      View in: PubMed
    577. Carbone PP, Spurr C, Schneiderman M, Scotto J, Holland JF, Shnider B. Management of patients with malignant lymphoma: a comparative study with cyclophosphamide and vinca alkaloids. Cancer Res. 1968 May; 28(5):811-22.
      View in: PubMed
    578. Kung F, Nyhan WL, Rosner F, Cortner JA, Cuttner J, Moon JH, Holland JF. Tryptophan mustard (NSC-62403) in the treatment of acute leukemia and malignant solid tumors in children. Cancer Chemother Rep. 1968 Apr; 52(3):445-50.
      View in: PubMed
    579. Regelson W, Kim U, Ospina J, Holland JF. Hemangioendothelial sarcoma of liver from chronic arsenic intoxication by Fowler's solution. Cancer. 1968 Mar; 21(3):514-22.
      View in: PubMed
    580. Iwata T, Iwata H, Holland JF. Isolation of albumin from human serum by means of trichloroacetic acid and ethanol. A comparison of methods. Clin Chem. 1968 Jan; 14(1):22-30.
      View in: PubMed
    581. Holland JF. Summary: recent advances in the treatment of acute leukemia and Burkitt's tumor. Cancer Res. 1967 Dec; 27(12):2633-5.
      View in: PubMed
    582. Hidvégi EJ, Lónai P, Holland J, Antoni F, Institoris L, Horváth IP. The effect of mannitol-myleran and two new dibromo-hexitols on the metabolic activities of nucleic acids and proteins. I. Biochem Pharmacol. 1967 Nov; 16(11):2143-53.
      View in: PubMed
    583. Ellison RR, Carey RW, Holland JF. Continuous infusions of arabinosyl cytosine in patients with neoplastic disease. Clin Pharmacol Ther. 1967 Nov-Dec; 8(6):800-9.
      View in: PubMed
    584. Holland JF, Korn R, O'Malley J, Minnemeyer HJ, Tieckelmann H. 5-allyl-2'-deoxyuridine inhibition of nucleoside phosphorylase in HeLa cells containing mycoplasma. Cancer Res. 1967 Oct; 27(10):1867-73.
      View in: PubMed
    585. Levine PH, Horoszewicz JS, Grace JT, Chai LS, Ellison RR, Holland JF. Relationship between clinical status of leukemic patients and virus-like particles in their plasma. Cancer. 1967 Oct; 20(10):1563-77.
      View in: PubMed
    586. Holland JF. Daunomycin treatment in acute leukemia. Pathol Biol. 1967 Oct; 15(19):929-32.
      View in: PubMed
    587. Regelson W, Holland JF, Gold GL, Lynch J, Olson KB, Horton J, Hall TC, Krant M, Colsky J, Miller SP, Owens A. 6-mercaptopurine (NSC-755) given intravenously at weekly intervals to patients with advanced cancer. Cancer Chemother Rep. 1967 Sep; 51(5):277-82.
      View in: PubMed
    588. Hall TC, Dederick MM, Chalmers TC, Krant MJ, Shnider BI, Lynch JJ, Holland JF, Ross C, Koons CR, Owens AH, Frei E, Brindley C, Miller SP, Brenner S, Hosley HF, Olson KB. A clinical pharmacologic study of chemotherapy and x-ray therapy in lung cancer. Am J Med. 1967 Aug; 43(2):186-93.
      View in: PubMed
    589. Carey RW, Holland JF, Sheehe PR, Graham S. Association of cancer of the breast and acute myelocytic leukemia. Cancer. 1967 Jul; 20(7):1080-8.
      View in: PubMed
    590. Hoogstraten B, Sheehe PR, Cuttner J, Cooper T, Kyle RA, Oberfield RA, Townsend SR, Harley JB, Hayes DM, Costa G, Holland JF. Melphalan in multiple myeloma. Blood. 1967 Jul; 30(1):74-83.
      View in: PubMed
    591. Regelson W, Holland JF, Talley RW. Clinical pharmacologic study of kethoxal bis(thiosemicarbazone) [NSC-82116] in advanced cancer. Cancer Chemother Rep. 1967 Jun; 51(3):171-7.
      View in: PubMed
    592. Kyle RA, Carbone PP, Lynch JJ, Owens AH, Costa G, Silver RT, Cuttner J, Harley JB, Leone LA, Shnider BI, Holland JF. Evaluation of tryptophan mustard (NSC-62403) in patients with plasmacytic myeloma. Cancer Res. 1967 Mar; 27(3):510-5.
      View in: PubMed
    593. Jones B, Kung F, Nyhan WL, Hananian J, Blom J, Burgert EO, Mills SD, Treat C, Wolman IJ, Chevalier L, Denton R, Sheehe P, Glidewell O, Holland JF. Chemotherapy of the leukemic transformation of lymphosarcoma. J Pediatr. 1967 Mar; 70(3):442-8.
      View in: PubMed
    594. Holland JF. Principles of chemotherapy of acute leukaemia. Triangle. 1967; 8(2):53-64.
      View in: PubMed
    595. Gailani S, Roque AL, Holland JF. The effect of pyridoxine deficiency on carcinoid syndrome. Study of a case of metastatic bronchial adenoma treated with induced vitamin B6 deficiency. Ann Intern Med. 1966 Nov; 65(5):1044-50.
      View in: PubMed
    596. Ohnuma T, Holland JF. Failure of urethane to influence early steps of pyrimidine biosynthesis in man. Clin Pharmacol Ther. 1966 Nov-Dec; 7(6):763-7.
      View in: PubMed
    597. Ohnuma T, Maldia G, Holland JF. Hepatic catalase activity in advanced human cancer. Cancer Res. 1966 Aug; 26(8):1806-18.
      View in: PubMed
    598. Carey RW, Pretlow TG, Ezdinli EZ, Holland JF. Studies on the mechanism of hypoglycemia in a patient with massive intraperitoneal leiomyosarcoma. Am J Med. 1966 Mar; 40(3):458-69.
      View in: PubMed
    599. Gailani SD, Armstrong JG, Carbone PP, Tan C, Holland JF. Clinical trial of vinleurosine sulfate (NSC-90636): a new drug derived from Vinca rosea Linn. Cancer Chemother Rep. 1966 Jan-Feb; 50(1):95-103.
      View in: PubMed
    600. Frei E, Karon M, Levin RH, Freireich EJ, Taylor RJ, Hananian J, Selawry O, Holland JF, Hoogstraten B, Wolman IJ, Abir E, Sawitsky A, Lee S, Mills SD, Burgert EO, Spurr CL, Patterson RB, Ebaugh FG, James GW, Moon JH. The effectiveness of combinations of antileukemic agents in inducing and maintaining remission in children with acute leukemia. Blood. 1965 Nov; 26(5):642-56.
      View in: PubMed
    601. Schwan TJ, Tieckelmann B, Holland JF, Bryant B. 2,4-dimethyl-5-hydroxymethylpyrimidine, a pyridoxol antagonist. J Med Chem. 1965 Nov; 8(6):750-3.
      View in: PubMed
    602. Holland JF. Formal discussion: the clinical pharmacology of anti-leukemia agents. Cancer Res. 1965 Oct; 25(9):1639-41.
      View in: PubMed
    603. FREI E, SPURR CL, BRINDLEY CO, SELAWRY O, HOLLAND JF, RALL DP, WASSERMAN LR, HOOGSTRATEN B, SHNIDER BI, MCINTYRE OR, MATTHEWS LB, MILLER SP. CLINICAL STUDIES OF DICHLOROMETHOTREXATE (NSC 29630). Clin Pharmacol Ther. 1965 Mar-Apr; 6:160-71.
      View in: PubMed
    604. REGELSON W, HOLLAND JF, FREI E, GOLD GL, HALL T, KRANT M, MILLER SO. COMPARATIVE CLINICAL TOXICITY OF 6-MERCAPTOPURINE (NSC-755)-1 AND 6-MERCAPTOPURINE RIBONUCLEOSIDE (NSC-4911)-2 ADMINISTERED INTRAVENOUSLY TO PATIENTS WITH ADVANCED CANCER. Cancer Chemother Rep. 1964 Mar; 36:41-8.
      View in: PubMed
    605. HOLLAND JF, REGELSON W, SELAWRY OS, COSTA G. METHYGLYOXAL-BIS-GUANYLHYDRAZONE--AN ACTIVE AGENT AGAINST HODGKIN'S DISEASE AND ACUTE MYELOBLASTIC LEUKEMIA. Acta Unio Int Contra Cancrum. 1964; 20:352-3.
      View in: PubMed
    606. HOLLAND JF. SUMMARY OF INFORMAL DISCUSSIONS ON CURRENT PROBLEMS WITH NEWER CHEMOTHERAPEUTIC AGENTS. Cancer Res. 1963 Sep; 23:1442-6.
      View in: PubMed
    607. HAKALA MT, HOLLAND JF, HOROSZEWICZ JS. Change in pyrimidine deoxyribonucleoside metabolism in cell culture caused by Mycoplasma (PPLO) contamination. Biochem Biophys Res Commun. 1963 Jun 20; 11:466-71.
      View in: PubMed
    608. REGELSON W, HOLLAND JF. Effect of an anionic polyelectrolyte (polyethylene sulfonate) in patients with cancer. Clinical pharmacology of a macromolecule. Clin Pharmacol Ther. 1962 Nov-Dec; 3:730-49.
      View in: PubMed
    609. COSTA G, HOLLAND JF. Effects of Krebs-2 carcinoma on the lipide metabolism of male Swiss mice. Cancer Res. 1962 Oct; 22:1081-3.
      View in: PubMed
    610. ZAK B, HOLLAND J, WILLIAMS LA. Logarithmic recording spectrophotometer for densitometry and flow spectrophotometry. Clin Chem. 1962 Sep-Oct; 8:530-7.
      View in: PubMed
    611. PARK RW, HOLLAND JF, JENKINS A. Urinary purines in leukemia. Cancer Res. 1962 May; 22:469-77.
      View in: PubMed
    612. HRESHCHYSHYN MM, HOLLAND JF. Chemotherapy in patients with gynecologic cancer. Am J Obstet Gynecol. 1962 Feb 15; 83:468-89.
      View in: PubMed
    613. HOSLEY HF, MARANGOUDAKIS S, ROSS CA, MURPHY WT, HOLLAND JF. Combined radiation-chemotherapy for bronchogenic carcinoma--pilot study. Cancer Chemother Rep. 1962 Feb; 16:467-71.
      View in: PubMed
    614. BRUEMMER NC, HOLLAND JF, SHEEHE PR. Drug effects on a target metabolic pathway and on mouse tumor growth: azauridine and decarboxylation of orotic acid-7-C-14. Cancer Res. 1962 Jan; 22:113-9.
      View in: PubMed
    615. HOLLAND JF. Chemotherapy and chemopraxis of cancer, 1961. Cancer Res. 1961 Oct; 21:1086-99.
      View in: PubMed
    616. FREI E, FRANZINO A, SHNIDER BI, COSTA G, COLSKY J, BRINDLEY CO, HOSLEY H, HOLLAND JF, GOLD GL, JONSSON U. Clinical studies of vinblastine. Cancer Chemother Rep. 1961 Jun; 12:125-9.
      View in: PubMed
    617. HRESHCHYSHYN MM, SHEEHAN FR, HOLLAND JF. Visualization of retroperitoneal lymph nodes. Lymphangiography as an aid in the measurement of tumor growth. Cancer. 1961 Jan-Feb; 14:205-9.
      View in: PubMed
    618. FREIREICH EJ, FREI E, HOLLAND JF, PINKEL D, SELAWRY O, ROTHBERG H, HAURANI F, TAYLOR R, GEHAN EA. Evaluation of a new chemotherapeutic agent in patients with 'advanced refractory' acute leukemia. Studies of 6-azauracil. Blood. 1960 Sep; 16:1268-78.
      View in: PubMed
    619. HOLLAND JF, HEIDELBERGER C. Human cancer, the primary target. Cancer Res. 1960 Aug; 20:975-6.
      View in: PubMed
    620. HOLLAND JF, SHARPE W, MAMROD LM, DOWD E, HARTSOCK M. Urate excretion in patients with acute leukemia. J Natl Cancer Inst. 1959 Nov; 23:1097-105.
      View in: PubMed
    621. GOLD GL, HALL TC, SHNIDER BJ, SELAWRY O, COLSKY J, OWENS AH, DEDERICK MM, HOLLAND JF, BRINDLEY CO, JONES R. A clinical study of 5-fluorouracil. Cancer Res. 1959 Oct; 19:935-9.
      View in: PubMed
    622. PETERS E, HOLLAND JF, BRYANT B, MINNEMEYER HJ, HOHENSTEIN C, TIECKELMANN H. Synthesis and tumorinhibitory properties of 2-methylthio-4-(substituted-anilino)-5-carbethoxypyrimidines. Cancer Res. 1959 Aug; 19:729-37.
      View in: PubMed
    623. FREI E, HOLLAND JF, SCHNEIDERMAN MA, PINKEL D, SELKIRK G, FREIREICH EJ, SILVER RT, GOLD GL, REGELSON W. A comparative study of two regimens of combination chemotherapy in acute leukemia. Blood. 1958 Dec; 13(12):1126-48.
      View in: PubMed
    624. HOLLAND JF, GUTHRIE R, TIECKELMANN H, CUDDIHY R. Experiments with some mouse tumors and leukemias. Cancer Res. 1958 Sep; 18(8 Part 2):335-9.
      View in: PubMed
    625. HOLLAND JF, GUTHRIE R, SHEEHE P, TIECKELMANN H. Inhibition of tumor growth in mice by a series of 2-substituted thiopyrimidines. Cancer Res. 1958 Aug; 18(7):776-80.
      View in: PubMed
    626. HOLLAND JF, REGELSON W. Studies of phenylalanine nitrogen mustard (CB 3025) in metastatic malignant melanoma of man. Ann N Y Acad Sci. 1958 Apr 24; 68(3):1122-5.
      View in: PubMed
    627. REGELSON W, HOLLAND JF. The anionic polyelectrolyte, polyethylene sulphonate, as a new anti-neoplastic agent. Nature. 1958 Jan 4; 181(4601):46-7.
      View in: PubMed
    628. REGELSON W, ZUCKERMAN P, HOLLAND JF. Co-ordinate-grid-mapping technique in medicine. Cancer. 1957 May-Jun; 10(3):437.
      View in: PubMed
    629. SAHAGIAN-EDWARDS A, HOLLAND JF. Metastatic carcinoma to the adrenal glands with cortical hypofunction. Cancer. 1954 Nov; 7(6):1242-5.
      View in: PubMed
    630. WEGRIA R, NICKERSON JL, CASE RB, HOLLAND JF. Effect of nitroglycerine on the cardiovascular system of normal persons. Am J Med. 1951 Apr; 10(4):414-8.
      View in: PubMed
    Holland's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067